Liang‐nian Ji

Liang‐nian Ji's AcademicInfluence.com Rankings

Liang‐nian Ji

Chemistry

#2491

World Rank

#3408

Historical Rank

Inorganic Chemistry

#106

World Rank

#117

Historical Rank

chemistry Degrees

Download Badge

Chemistry

Liang‐nian Ji's Degrees

PhD Chemistry Peking University

Why Is Liang‐nian Ji Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Liang‐nian Ji's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials. (2017) (521)
Shape- and enantioselective interaction of Ru(II)/Co(III) polypyridyl complexes with DNA (2001) (379)
DNA-binding and photocleavage studies of cobalt(III) polypyridyl complexes: [Co(phen)2IP]3+ and [Co(phen)2PIP]3+ (2001) (343)
Highly Charged Ruthenium(II) Polypyridyl Complexes as Lysosome-Localized Photosensitizers for Two-Photon Photodynamic Therapy. (2015) (310)
DNA-binding and cleavage studies of macrocyclic copper(II) complexes. (2002) (292)
Interaction of [Ru(dmp)2(dppz)]2+ and [Ru(dmb)2(dppz)]2+ with DNA: effects of the ancillary ligands on the DNA-binding behaviors. (2001) (245)
DNA interactions of a functionalized ruthenium(II) mixed-polypyridyl complex [Ru(bpy)2ppd]2+. (2006) (243)
DNA binding studies of ruthenium(II) complexes containing asymmetric tridentate ligands. (2002) (207)
Nuclear permeable ruthenium(II) β-carboline complexes induce autophagy to antagonize mitochondrial-mediated apoptosis. (2010) (206)
Ruthenium(II) polypyridyl complexes as mitochondria-targeted two-photon photodynamic anticancer agents. (2015) (195)
Bis(2,2′-bipyridine)ruthenium(II)complexes withimidazo[4,5-f ][1,10]-phenanthroline or2-phenylimidazo[4,5-f ][1,10]phenanthroline (1997) (193)
Synthesis, structural characteristics, DNA binding properties and cytotoxicity studies of a series of Ru(III) complexes. (2008) (190)
Synthesis, DNA-binding and DNA-mediated luminescence quenching of Ru(II) polypyridine complexes (1999) (185)
Phosphorescent iridium(III)-bis-N-heterocyclic carbene complexes as mitochondria-targeted theranostic and photodynamic anticancer agents. (2015) (183)
Effects of ligand planarity on the interaction of polypyridyl Ru(II) complexes with DNA (2003) (178)
Targeting nucleus DNA with a cyclometalated dipyridophenazineruthenium(II) complex. (2014) (177)
Two-photon luminescent metal complexes for bioimaging and cancer phototherapy (2016) (176)
Multifunctional QD-based co-delivery of siRNA and doxorubicin to HeLa cells for reversal of multidrug resistance and real-time tracking. (2012) (172)
Interaction of polypyridyl ruthenium(II) complexes containing non-planar ligands with DNA (1999) (155)
Interaction of macrocyclic copper(II) complexes with calf thymus DNA: effects of the side chains of the ligands on the DNA-binding behaviors (2003) (155)
Polypyridyl ruthenium(II) complexes containing intramolecular hydrogen-bond ligand: syntheses, characterization, and DNA-binding properties (1999) (154)
Cyclodextrin and Polyethylenimine Functionalized Mesoporous Silica Nanoparticles for Delivery of siRNA Cancer Therapeutics (2014) (154)
Co-Delivery of Cisplatin Prodrug and Chlorin e6 by Mesoporous Silica Nanoparticles for Chemo-Photodynamic Combination Therapy to Combat Drug Resistance. (2016) (150)
Organelle-targeting metal complexes: From molecular design to bio-applications (2017) (146)
Synthesis, characterization and DNA-binding of novel chiral complexes Δ- and Λ-[Ru(bpy)2L]2+ (L = o-mopip and p-mopip) (2006) (145)
Differences in structure, physiological stability, electrochemistry, cytotoxicity, DNA and protein binding properties between two Ru(III) complexes. (2008) (145)
DNA interactions of cobalt(III) mixed-polypyridyl complexes containing asymmetric ligands. (2004) (143)
Theranostic iridium(III) complexes as one- and two-photon phosphorescent trackers to monitor autophagic lysosomes. (2014) (142)
Dual-Enzyme Characteristics of Polyvinylpyrrolidone-Capped Iridium Nanoparticles and Their Cellular Protective Effect against H2O2-Induced Oxidative Damage. (2015) (142)
Study of the interaction between novel ruthenium(II)-polypyridyl complexes and calf thymus DNA. (1997) (135)
Insights into metalloenzyme microenvironments: biomimetic metal complexes with a functional second coordination sphere. (2013) (135)
The induction of mitochondria-mediated apoptosis in cancer cells by ruthenium(II) asymmetric complexes. (2013) (130)
Effects of the ancillary ligands of polypyridyl ruthenium(II) complexes on the DNA-binding behaviors (2003) (127)
The design of new molecular "light switches" for DNA (2001) (126)
Graphene Oxide Decorated with Ru(II)-Polyethylene Glycol Complex for Lysosome-Targeted Imaging and Photodynamic/Photothermal Therapy. (2017) (120)
Noncovalent Ruthenium(II) Complexes-Single-Walled Carbon Nanotube Composites for Bimodal Photothermal and Photodynamic Therapy with Near-Infrared Irradiation. (2015) (119)
Synthesis, characterization, DNA-binding and photocleavage of complexes [Ru(phen)2(6-OH-dppz)]2+ and [Ru(phen)2(6-NO2-dppz)]2+. (2005) (119)
Harnessing ruthenium(II) as photodynamic agents: Encouraging advances in cancer therapy (2018) (117)
Synthesis, characterization, DNA-binding and spectral properties of complexes [Ru(L)4(dppz)]2+ (L=Im and MeIm). (2008) (117)
Synthesis, DNA-binding and topoisomerase inhibitory activity of ruthenium(II) polypyridyl complexes. (2011) (114)
Cleavage of double-strand DNA by linear and triangular trinuclear copper complexes. (2006) (110)
A mathematical model for gluconic acid fermentation by Aspergillus niger (2003) (109)
Optimization of glucose oxidase production by Aspergillus niger in a benchtop bioreactor using response surface methodology (2003) (108)
Synthesis, characterization and the effect of ligand planarity of [Ru(bpy)2L]2+ on DNA binding affinity. (1999) (107)
Phosphorescent iridium(III) complexes as multicolor probes for specific mitochondrial imaging and tracking. (2014) (105)
Targeting cancer cell metabolism with mitochondria-immobilized phosphorescent cyclometalated iridium(iii) complexes† †Electronic supplementary information (ESI) available: Experimental procedures, figures and tables, references and X-ray crystallographic data. CCDC 1452036–1452038. For ESI and cryst (2016) (102)
Comparison between polypyridyl and cyclometalated ruthenium(II) complexes: anticancer activities against 2D and 3D cancer models. (2015) (102)
Synthesis, crystal structure, DNA interaction and anticancer activity of tridentate copper(II) complexes. (2013) (99)
Synthesis, characterization, DNA-binding and photocleavage studies of [Ru(bpy)2(PPIP)]2+ and [Ru(phen)2(PPIP)]2+. (2005) (99)
Interaction of [Ru(bpy)2(dppz)]2+ with human telomeric DNA: preferential binding to G-quadruplexes over i-motif. (2010) (99)
Interaction of polypyridyl ruthenium (II) complex containing asymmetric ligand with DNA. (2005) (99)
Multifunctional quantum-dot-based siRNA delivery for HPV18 E6 gene silence and intracellular imaging. (2011) (99)
A mitochondrial targeted two-photon iridium(III) phosphorescent probe for selective detection of hypochlorite in live cells and in vivo. (2015) (97)
Double-strand DNA cleavage by copper complexes of 2,2'-dipyridyl with electropositive pendants. (2006) (97)
Impacts of Cd(II) on the conformation and self-aggregation of Alzheimer's tau fragment corresponding to the third repeat of microtubule-binding domain. (2007) (95)
Synthesis, characterization and DNA-binding properties of novel dipyridophenazine complex of ruthenium (II) : [Ru(IP)2(DPPZ)]2+ (1999) (94)
Multifunctional Gold Nanorods for siRNA Gene Silencing and Photothermal Therapy (2014) (94)
Experimental and theoretical study on DNA-binding and photocleavage properties of chiral complexes Δ- and Λ-[Ru(bpy)2L](L =o-hpip, m-hpip and p-hpip) (2003) (94)
A dinuclear iridium(III) complex as a visual specific phosphorescent probe for endogenous sulphite and bisulphite in living cells (2013) (94)
Synthesis, crystal structure and DNA cleavage activities of copper(II) complexes with asymmetric tridentate ligands. (2004) (93)
Chiral ruthenium(II) anthraquinone complexes as dual inhibitors of topoisomerases I and II (2011) (91)
DNA-binding and photocleavage studies of cobalt(III) mixed-polypyridyl complexes containing 2-(2-chloro-5-nitrophenyl)imidazo [4,5-f][1,10]phenanthroline. (2001) (91)
Synthesis, structures, cellular uptake and apoptosis-inducing properties of highly cytotoxic ruthenium-Norharman complexes. (2011) (90)
Metallomics insights into the programmed cell death induced by metal-based anticancer compounds. (2014) (89)
Synthesis, DNA-binding and photocleavage studies of ruthenium complexes [Ru(bpy)2(mitatp)]2+ and [Ru(bpy)2(nitatp)]2+. (2009) (89)
Enantiomeric ruthenium(II) complexes binding to DNA: binding modes and enantioselectivity (2000) (88)
Synthesis, antitumor activity and structure-activity relationships of a series of Ru(II) complexes. (2008) (88)
Selectively lighting up two-photon photodynamic activity in mitochondria with AIE-active iridium(iii) complexes. (2017) (87)
Syntheses, characterization and DNA-binding studies of ruthenium(II) terpyridine complexes: [Ru(tpy)(PHBI)]2+ and [Ru(tpy)(PHNI)]2+. (2003) (85)
Cyclometalated Ir(III) complexes as targeted theranostic anticancer therapeutics: combining HDAC inhibition with photodynamic therapy. (2014) (84)
Synthesis, characterization and luminiscent DNA-binding study of a series of ruthenium complexes containing 2-arylimidazo[f]1,10-phenanthroline (1997) (84)
Complexation, structure, and superoxide dismutase activity of the imidazolate-bridged dinuclear copper moiety with beta-cyclodextrin and its guanidinium-containing derivative. (2006) (84)
Effect of intramolecular hydrogen-bond on the DNA-binding and photocleavage properties of polypyridyl cobalt(III) complexes (2002) (83)
Dual Functions of Cyclometalated Iridium(III) Complexes: Anti-Metastasis and Lysosome-Damaged Photodynamic Therapy. (2017) (83)
Electronic effect of different positions of the -NO2 group on the DNA-intercalator of chiral complexes [Ru(bpy)2L]2+ (L =o-npip, m-npip and p-npip). (2005) (82)
Ruthenium(II) Complexes with 2-Phenylimidazo[4,5-f][1,10]phenanthroline Derivatives that Strongly Combat Cisplatin-Resistant Tumor Cells (2016) (81)
The indenyl ligand effect on the rate of substitution reactions of Rh(η-C9H7)(CO)2 and Mn(η-C9H7)(CO)3 (1983) (80)
Mono- and bi-nuclear ruthenium(II) complexes containing a new asymmetric ligand 3-(pyrazin-2-yl)-as-triazino[5,6-f ]1,10-phenanthroline: synthesis, characterization and DNA-binding properties (1999) (80)
Targeting topoisomerase II with the chiral DNA-intercalating ruthenium(II) polypyridyl complexes (2007) (80)
Synthesis, DNA-binding and photocleavage studies of cobalt(III) mixed-polypyridyl complexes: [Co(phen)(2)(dpta)](3+) and [Co(phen)(2)(amtp)](3+). (2007) (79)
Molecular "light switch" for G-quadruplexes and i-motif of human telomeric DNA: [Ru(phen)2(dppz)]2+. (2010) (79)
Photophysical properties and singlet oxygen generation of three sets of halogenated corroles. (2012) (76)
Ruthenium(ii) complexes with dppz: from molecular photoswitch to biological applications. (2016) (75)
Biophysical studies of a ruthenium(II) polypyridyl complex binding to DNA and RNA prove that nucleic acid structure has significant effects on binding behaviors (2005) (75)
DNA condensation induced by ruthenium(II) polypyridyl complexes [Ru(bpy)(2)(PIPSH)](2+) and [Ru(bpy)(2)(PIPNH)](2+). (2009) (74)
Delivery of Phosphorescent Anticancer Iridium(III) Complexes by Polydopamine Nanoparticles for Targeted Combined Photothermal‐Chemotherapy and Thermal/Photoacoustic/Lifetime Imaging (2018) (72)
DNA condensation induced by metal complexes (2014) (72)
Experimental and DFT studies on the DNA-binding trend and spectral properties of complexes [Ru(bpy)2L]2+ (L = dmdpq, dpq, and dcdpq) (2005) (72)
Promoting the formation and stabilization of G-quadruplex by dinuclear RuII complex Ru2(obip)L4. (2008) (71)
Monitoring mitochondrial viscosity with anticancer phosphorescent Ir(iii) complexes via two-photon lifetime imaging (2018) (71)
Enhanced production of extracellular ribonuclease from Aspergillus niger by optimization of culture conditions using response surface methodology (2004) (71)
A dinuclear ruthenium(II) complex as a one- and two-photon luminescent probe for biological Cu(2+) detection. (2013) (70)
Synthesis, GC selective DNA binding and topoisomerase II inhibition activities of ruthenium(II) polypyridyl complex containing 11-aminopteridino[6,7-f][1,10]phenanthrolin-13(12H)-one. (2008) (70)
Mono- and Dinuclear Phosphorescent Rhenium(I) Complexes: Impact of Subcellular Localization on Anticancer Mechanisms. (2016) (69)
Dinuclear ruthenium(II) polypyridyl complexes as single and two-photon luminescence cellular imaging probes. (2014) (69)
Super-Resolution Tracking of Mitochondrial Dynamics with An Iridium(III) Luminophore. (2018) (68)
Mitochondria-specific phosphorescent imaging and tracking in living cells with an AIPE-active iridium(III) complex. (2013) (68)
A GSH-activatable ruthenium(ii)-azo photosensitizer for two-photon photodynamic therapy. (2017) (68)
Cyclometalated Ruthenium(II) Anthraquinone Complexes Exhibit Strong Anticancer Activity in Hypoxic Tumor Cells. (2015) (67)
Experimental and theoretical studies on the DNA-binding and spectral properties of water-soluble complex [Ru(MeIm) 4 (dpq)] 2+ (2008) (66)
Histone-deacetylase-targeted fluorescent ruthenium(II) polypyridyl complexes as potent anticancer agents. (2013) (66)
Mitochondria are the primary target in the induction of apoptosis by chiral ruthenium(II) polypyridyl complexes in cancer cells (2014) (66)
Long-Term Lysosomes Tracking with a Water-Soluble Two-Photon Phosphorescent Iridium(III) Complex. (2016) (65)
Kinetics and mechanism of substitution reactions of Mn(.eta.5-C9H7)(CO)3 and Mn(.eta.5-C13H9)(CO)3 (1984) (65)
Electronic effects on the interactions of complexes [Ru(phen)2(p-L)]2+ (L=MOPIP, HPIP, and NPIP) with DNA (2004) (64)
Enhanced dye decolorization efficiency by citraconic anhydride-modified horseradish peroxidase (2006) (64)
An effective approach to artificial nucleases using copper(II) complexes bearing nucleobases. (2010) (63)
Simultaneously Inducing and Tracking Cancer Cell Metabolism Repression by Mitochondria-Immobilized Rhenium(I) Complex. (2017) (63)
A functionalized cobalt(III) mixed-polypyridyl complex as a newly designed DNA molecular light switch. (2003) (63)
Reaction of divalent metal acetate and 2,2′-bipyridine. Syntheses and structural characterization of mono-, bi- and tri-nuclear complexes (2000) (63)
Double-strand DNA cleavage by copper complexes of 2,2'-dipyridyl with guanidinium/ammonium pendants. (2008) (62)
Ruthenium(II) anthraquinone complexes as two-photon luminescent probes for cycling hypoxia imaging in vivo. (2015) (62)
Stability of metal ion complexes formed with methyl phosphate and hydrogen phosphate (1996) (62)
Synthesis, structure, and activity of supramolecular mimics for the active site and arg141 residue of copper, zinc-superoxide dismutase. (2007) (61)
Syntheses, characterization and third order non-linear optical properties of the ruthenium(II) complexes containing 2-phenylimidazo[4,5-f][1,10]phenanthroline derivatives† (1999) (61)
Anticancer Cyclometalated Iridium(III) Complexes with Planar Ligands: Mitochondrial DNA Damage and Metabolism Disturbance. (2019) (61)
Increased thermostability and phenol removal efficiency by chemical modified horseradish peroxidase (2002) (60)
A mitochondria-targeting magnetothermogenic nanozyme for magnet-induced synergistic cancer therapy. (2020) (60)
Effects of the substitution positions of Br group in intercalative ligand on the DNA-binding behaviors of Ru(II) polypyridyl complexes. (2004) (59)
Synthesis, characterization and DNA binding of ruthenium(II) complexes containing the atatp ligand. (2000) (59)
Phosphodiester hydrolysis and specific DNA binding and cleavage promoted by guanidinium-functionalized zinc complexes. (2009) (59)
Ruthenium-Arene-β-Carboline Complexes as Potent Inhibitors of Cyclin-Dependent Kinase 1: Synthesis, Characterization and Anticancer Mechanism Studies. (2013) (59)
Ruthenium(II) mixed-ligand complexes containing 2-(6-methyl-3-chromonyl)imidazo[4,5-f][1,10]-phenanthroline: Synthesis, DNA-binding and photocleavage studies (2006) (59)
Light-Up Mitophagy in Live Cells with Dual-Functional Theranostic Phosphorescent Iridium(III) Complexes. (2017) (59)
Synthesis, DNA-binding and cleavage studies of macrocyclic copper(II) complexes (2003) (58)
Synthesis, characterization, DNA-binding and cleavage studies of [Ru(bpy)2(actatp)]2+ and [Ru(phen)2(actatp)]2+ (actatp=acenaphthereno[1,2-b]-1,4,8,9-tetraazariphenylence). (2003) (58)
Phosphorescent iridium(iii) complexes as multicolour probes for imaging of hypochlorite ions in mitochondria. (2014) (58)
Antitumor properties and mechanisms of mitochondria-targeted Ag(I) and Au(I) complexes containing N-heterocyclic carbenes derived from cyclophanes. (2014) (57)
Cyclometalated Iridium(III) Complexes as Two-Photon Phosphorescent Probes for Specific Mitochondrial Dynamics Tracking in Living Cells. (2015) (57)
Real-time tracking mitochondrial dynamic remodeling with two-photon phosphorescent iridium (III) complexes. (2016) (57)
Mono-, di- and tetra-nuclear ruthenium(II) complexes containing 2,2′-p-phenylenebis(imidazo[4,5-f ]phenanthroline): synthesis, characterization and third-order non-linear optical properties (2001) (56)
Multifunctional low-temperature photothermal nanodrug with in vivo clearance, ROS-Scavenging and anti-inflammatory abilities. (2019) (56)
Coumarin-appended phosphorescent cyclometalated iridium(iii) complexes as mitochondria-targeted theranostic anticancer agents. (2016) (55)
Synthesis, biocompatibility and cell labeling of L-arginine-functional beta-cyclodextrin-modified quantum dot probes. (2010) (54)
Crossfire for Two-Photon Photodynamic Therapy with Fluorinated Ruthenium (II) Photosensitizers. (2017) (53)
An ER-Targeting Iridium(III) Complex which Induces Immunogenic Cell Death in Non-Small Cell Lung Cancer. (2020) (53)
Iridium(III) Anthraquinone Complexes as Two-Photon Phosphorescence Probes for Mitochondria Imaging and Tracking under Hypoxia. (2016) (53)
A luminescent pH sensor based on a diruthenium(II) complex: `off–on–off' switching via the protonation/deprotonation of an imidazole-containing ligand (1999) (53)
Dinuclear ruthenium(II) complexes that induce and stabilise G-quadruplex DNA. (2015) (52)
DNA Binding, Photocleavage, and Topoisomerase Inhibition of Functionalized Ruthenium(II)‐Polypyridine Complexes (2008) (51)
Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA (2013) (51)
Ester hydrolysis by a cyclodextrin dimer catalyst with a metallophenanthroline linking group. (2008) (51)
Cyclometalated iridium(iii) complexes induce mitochondria-derived paraptotic cell death and inhibit tumor growth in vivo. (2018) (51)
Density functional theory/time-dependent DFT studies on the structures, trend in DNA-binding affinities, and spectral properties of complexes [Ru(bpy)2(p-R-pip)]2+ (R = -OH, -CH3, -H, -NO2). (2006) (51)
DNA Interactions with Ruthenium(ll) Polypyridine Complexes Containing Asymmetric Ligands (2005) (51)
A fast and selective two-photon phosphorescent probe for the imaging of nitric oxide in mitochondria. (2015) (51)
A ruthenium(II) complex inhibits tumor growth in vivo with fewer side-effects compared with cisplatin. (2015) (51)
Synthesis, characterization and interaction of mixed polypyridyl ruthenium(II) complexes with calf thymus DNA (2001) (51)
Unexpected high photothemal conversion efficiency of gold nanospheres upon grafting with two-photon luminescent ruthenium(II) complexes: A way towards cancer therapy? (2015) (51)
Synthesis, DNA interaction and anticancer activity of copper(II) complexes with 4'-phenyl-2,2':6',2″-terpyridine derivatives. (2014) (51)
Supramolecular self-assembled nanoparticles for chemo-photodynamic dual therapy against cisplatin resistant cancer cells. (2015) (50)
A Mitochondrion-Localized Two-Photon Photosensitizer Generating Carbon Radicals against Hypoxic Tumors. (2020) (50)
Synthesis, DNA-binding and photocleavage studies of ruthenium(II) complex with 2-(3'-phenoxyphenyl)imidazo[4,5-f][1,10]phenanthroline. (2007) (50)
Multi-step encapsulation of chemotherapy and gene silencing agents in functionalized mesoporous silica nanoparticles. (2017) (50)
Azo-Based Iridium(III) Complexes as Multicolor Phosphorescent Probes to Detect Hypoxia in 3D Multicellular Tumor Spheroids (2015) (49)
Oncosis-inducing cyclometalated iridium(iii) complexes† †Electronic supplementary information (ESI) available: Experimental section, NMR, ES-MS, photophysical properties, crystal structure and data, confocal images, cell viability and IC50 values. CCDC 1578910. For ESI and crystallographic data in C (2018) (49)
Content Detection of G-Quadruplex DNA in Live Cells Based on Photon Counts and Complex Structures. (2020) (49)
Cyclometalated iridium(III)-β-carboline complexes as potent autophagy-inducing agents. (2014) (49)
Visual specific luminescent probing of hybrid G-quadruplex DNA by a ruthenium polypyridyl complex. (2012) (49)
Thiol-specific phosphorescent imaging in living cells with an azobis(2,2'-bipyridine)-bridged dinuclear iridium(III) complex. (2013) (49)
Synthesis, characterization and dna binding study of Co(III) polypyridyl mixed-ligand complexes (1998) (48)
Studies on synthesis, characterization, and G-quadruplex binding of Ru(II) complexes containing two dppz ligands. (2011) (48)
Effects of the ancillary ligands of polypyridyl ruthenium(II) complexes on the DNA-binding and photocleavage behaviors (2007) (47)
A Tailored Multifunctional Anticancer Nanodelivery System for Ruthenium‐Based Photosensitizers: Tumor Microenvironment Adaption and Remodeling (2019) (47)
Reversal of multidrug resistance in MCF-7/Adr cells by codelivery of doxorubicin and BCL2 siRNA using a folic acid-conjugated polyethylenimine hydroxypropyl-β-cyclodextrin nanocarrier (2015) (47)
Synthesis, characterization and antiviral activity against influenza virus of a series of novel manganese-substituted rare earth borotungstates heteropolyoxometalates. (2004) (47)
Synthesis, characterization, structures and DNA-binding properties of complexes [Ru(bpy)2(L)]2+ (L = ptdb, ptda and ptdp) with asymmetric intercalative ligands (2005) (46)
In vitro transcription inhibition by ruthenium(II) polypyridyl complexes with electropositive ancillary ligands. (2009) (46)
Tricationic pyridium porphyrins appending different peripheral substituents: experimental and DFT studies on their interactions with DNA. (2008) (46)
Mn(III) porphyrins immobilized on magnetic polymer nanospheres as biomimetic catalysts hydroxylating cyclohexane with molecular oxygen (2009) (45)
Direct imaging of biological sulfur dioxide derivatives in vivo using a two-photon phosphorescent probe. (2015) (45)
On the Dichotomy of Metal Ion Binding in Adenosine Complexes (1992) (45)
A theoretical study on the hydrolysis process of the antimetastatic ruthenium(III) complex NAMI-A. (2007) (45)
Enhanced cancer therapy by the marriage of metabolic alteration and mitochondrial-targeted photodynamic therapy using cyclometalated Ir(iii) complexes. (2017) (45)
pH responsive “off–on–off” luminescent switch of a novel ruthenium(II) complex [Ru(bpy)2(pipipH2)]2+ (2007) (44)
Synthesis, characterization, antiproliferative and anti-metastatic properties of two ruthenium-DMSO complexes containing 2,2'-biimidazole. (2011) (44)
Ruthenium(II) complexes containing asymmetric ligands: synthesis, characterization, crystal structure and DNA-binding (2003) (44)
1,10-Phenanthroline platinum(II) complex: a simple molecule for efficient G-quadruplex stabilization. (2010) (44)
Syntheses and characterization of two monomeric zinc complexes containing aqua ligands (1999) (43)
Cyclometalated Iridium(III) Complexes as AIE Phosphorescent Probes for Real-Time Monitoring of Mitophagy in Living Cells (2016) (43)
DNA-binding and photoactivated enantiospecific cleavage of chiral polypyridyl ruthenium(II) complexes. (2004) (43)
Synthesis, characterization and biological evaluation of mixed-ligand ruthenium(II) complexes for photodynamic therapy. (2015) (43)
Targeted cellular uptake and siRNA silencing by quantum-dot nanoparticles coated with β-cyclodextrin coupled to amino acids. (2011) (43)
DNA-binding and photocleavage properties of cationic porphyrin-anthraquinone hybrids with different lengths of links. (2008) (43)
Mixed-ligand iridium(iii) complexes as photodynamic anticancer agents. (2017) (42)
Three transition metal complexes formed with tripodal polyimidazole ligands: synthesis, crystal structures and reactivity toward superoxide (2001) (42)
Targeting telomeric G-quadruplexes with the ruthenium(II) complexes [Ru(bpy)(2)(ptpn)](2+) and [Ru(phen)(2)(ptpn)](2+). (2013) (42)
Biscylometalated iridium(iii) complexes target mitochondria or lysosomes by regulating the lipophilicity of the main ligands. (2016) (42)
Mitochondrial dynamics tracking with iridium(III) complexes. (2018) (42)
Platinum(II)-triarylpyridines complexes with electropositive pendants as efficient G-quadruplex binders. (2011) (42)
Cyclometalated iridium(iii) N-heterocyclic carbene complexes as potential mitochondrial anticancer and photodynamic agents. (2017) (42)
Synthesis, characterization, DNA-binding and DNA-photocleavage studies of [Ru(bpy)2(pmip)]2+ and [Ru(phen)2(pmip)]2+ (pmip = 2-(2′-pyrimidyl)imidazo[4,5-f][1,10]phenanthroline (2007) (42)
[NiL]3[BTC]2·14H2O [L = 3,10-bis(2-ethyl)-1,3,5,8,10,12-hexaazacyclotetradecane, BTC = 1,3,5-benzenetricarboxylate]: synthesis, structure and unique selective guest molecule absorption properties (2002) (42)
Pt(II) squares as selective and effective human telomeric G-quadruplex binders and potential cancer therapeutics. (2012) (41)
Influence of the counter ions and ligands on structures of silver(I) helicates with di-Schiff bases containing imidazole groups (2000) (41)
Synthesis, characterization and DNA-binding studies of cobalt(III) polypyridyl complexes (2001) (41)
Dual topoisomerase I and II poisoning by chiral Ru(II) complexes containing 2-thiophenylimidazo[4,5-f][1,10]phenanthroline derivatives. (2014) (41)
DNA-binding and cleavage studies of a novel porphyrin ruthenium mixed complex [MPyTPP—Ru(pip)2Cl]+ (2003) (40)
Targeted reversal and phosphorescence lifetime imaging of cancer cell metabolism via a theranostic rhenium(I)-DCA conjugate. (2018) (40)
DNA binding and photocleavage specificities of a group of tricationic metalloporphyrins. (2010) (40)
Synthesis, characterization, and anticancer activity of ruthenium(II)-β-carboline complex. (2013) (40)
Molecular "light switch" for G-quadruplex DNA: cycling the switch on and off. (2012) (39)
DNA binding and photocleavage properties of a novel cationic porphyrin-anthraquinone hybrid. (2008) (39)
Chiral ruthenium(II) complexes with phenolic hydroxyl groups as dual poisons of topoisomerases I and IIα. (2013) (38)
Increased thermal and organic solvent tolerance of modified horseradish peroxidase. (2006) (38)
Ruthenium(II) polypyridyl complexes as dual inhibitors of telomerase and topoisomerase. (2015) (37)
Cleavage of double-strand DNA by zinc complexes of dicationic 2,2'-dipyridyl derivatives. (2007) (37)
Self-activating nuclease and anticancer activities of copper(II) complexes with aryl-modified 2,6-di(thiazol-2-yl)pyridine. (2013) (37)
Platinum squares with high selectivity and affinity for human telomeric G-quadruplexes. (2012) (37)
Two-photon photodynamic ablation of tumor cells by mitochondria-targeted iridium(iii) complexes in aggregate states. (2017) (37)
CAIXplatins: Highly Potent Platinum(IV) Prodrugs Selective Against Carbonic Anhydrase IX for the Treatment of Hypoxic Tumors (2020) (37)
Ruthenium complex-modified carbon nanodots for lysosome-targeted one- and two-photon imaging and photodynamic therapy. (2017) (37)
Synthesis, Characterization and Antitumor Activity of a Series of Polypyridyl Complexes (2000) (37)
Treatment of aqueous chlorophenol by phthalic anhydride-modified horseradish peroxidase (2003) (37)
A phosphorescent rhenium(I) histone deacetylase inhibitor: mitochondrial targeting and paraptosis induction. (2015) (36)
Effects of phthalic anhydride modification on horseradish peroxidase stability and structure (2005) (36)
Synthesis, electrochemical and spectroscopic properties of ruthenium(II) complexes containing 1,3-bis([1,10]phenanthroline-[5,6-d]imidazol-2-yl)benzene (2000) (36)
Mononuclear nickel complexes assembled into two-dimensional networks via hydrogen bonds and π–π stacking interactions (1998) (36)
Polymeric and tetranuclear silver(I) chains encapsulated by a scorpion-like ligand. Synthesis and st (2000) (36)
Enantiopreferential DNA-binding of a novel dinuclear complex [(bpy)2Ru(bdptb)Ru(bpy)2]4+ (2003) (36)
Mitochondria-targeted two-photon fluorescent probe for the detection of biothiols in living cells (2018) (36)
Two novel zinc complexes of disubstituted 2,2?bipyridine with ammonium groups as artificial nucleases (2008) (35)
Molecular hairpin: a possible model for inhibition of tau aggregation by tannic acid. (2013) (35)
Experimental and DFT studies on DNA binding and photocleavage of two cationic porphyrins. Effects of the introduction of a carboxyphenyl into pyridinium porphyrin. (2008) (35)
Synthesis, characterization and DNA-binding properties of [Ru(phen)2taptp]2+ and [Ru(phen)2dptatp]2+ (2000) (35)
Mitochondria-Accumulating Rhenium(I) Tricarbonyl Complexes Induce Cell Death via Irreversible Oxidative Stress and Glutathione Metabolism Disturbance. (2019) (35)
A luminescent tetranuclear ruthenium(II) complex as a tracking non-viral gene vector. (2013) (35)
Ester-Modified Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents (2016) (35)
Synthesis, characterization and DNA-binding studies of ruthenium(II) mixed-ligand complexes containing dipyrido[1,2,5]oxadiazolo[3,4-b]quinoxaline. (2009) (34)
DNA-binding and photocleavage studies of [Ru(phen)2(NMIP)]2+ (2005) (34)
Cancer cell membrane camouflaged iridium complexes functionalized black-titanium nanoparticles for hierarchical-targeted synergistic NIR-II photothermal and sonodynamic therapy. (2021) (34)
Dual inhibition of topoisomerases I and IIα by ruthenium(II) complexes containing asymmetric tridentate ligands. (2014) (34)
Redox responsive luminescent switch based on a ruthenium(II) complex [Ru(bpy)2(PAIDH)]2+ (2008) (34)
RuNH2@AuNPs as two-photon luminescent probes for thiols in living cells and tissues. (2014) (34)
Endoplasmic reticulum targeted cyclometalated iridium(iii) complexes as efficient photodynamic therapy photosensitizers. (2019) (34)
Synthesis, structure and nuclease activity of copper complexes of disubstituted 2,2′-bipyridine ligands bearing ammonium groups (2008) (34)
Valproic Acid-Functionalized Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents. (2017) (33)
Bis(2,2′-bipyridine)cobalt(III) complexes containing asymmetric ligands: Synthesis, DNA-binding and photocleavage studies (2005) (33)
Intercalation into calf thymus DNA of 2-(4-arylphenyl)imidazo[4,5-f]-[1,10]phenanthroline (aryl = -OMe, -NMe2 or -NO2) in its bipyridyl ruthenium(II) complex (1998) (33)
Synthesis, crystal structure and DNA-binding properties of ruthenium(II) polypyridyl complexes with dicationic 2,2′-dipyridyl derivatives as ligands (2008) (33)
Electronic structures, DNA-binding and related properties of complexes [Ru(bpy)2L]2+ (L=ip, pip, hpip) (2004) (33)
Fluorescence properties of halogenated mono-hydroxyl corroles: the heavy-atom effects (2009) (33)
Oxygen self-sufficient photodynamic therapy (2020) (33)
Metalloporphyrin-catalyzed hydroxylation of cyclohexane with molecular oxygen (1991) (33)
Effect of ancillary ligands on the topoisomerases II and transcription inhibition activity of polypyridyl ruthenium(II) complexes. (2010) (32)
An Ultrasmall RuO2 Nanozyme Exhibiting Multienzyme-like Activity for the Prevention of Acute Kidney Injury. (2020) (32)
A combined computational and experimental study on DNA-photocleavage of Ru(II) polypyridyl complexes [Ru(bpy)2(L)]2+ (L = pip, o-mopip and p-mopip). (2008) (32)
FerriIridium: A Lysosome-Targeting Iridium(III) Prodrug for Iron(III)-Activated Chemotherapy in Gastric Cancer Cells. (2019) (31)
Rational design of NIR-emitting iridium(iii) complexes for multimodal phosphorescence imaging of mitochondria under two-photon excitation. (2017) (31)
Silica-metalloporphyrins hybrid materials: preparation and catalysis to hydroxylate cyclohexane with molecular oxygen (2009) (31)
Theoretical studies on the excited states, DNA photocleavage, and spectral properties of complex [Ru(phen)(2)(6-OH-dppz)](2+). (2007) (31)
Synthesis, characterization and biological evaluation of labile intercalative ruthenium(ii) complexes for anticancer drug screening. (2016) (31)
A DFT/TDDFT study on the structures, trend in DNA-binding and spectral properties of molecular “light switch” complexes [Ru(phen)2(L)]2+(L = dppz, taptp, phehat) (2007) (31)
Lipophilic tetranuclear ruthenium(II) complexes as two-photon luminescent tracking non-viral gene vectors. (2015) (31)
Magnetic Polymer Nanospheres Immobilizing Metalloporphyrins. Catalysis and Reuse to Hydroxylate Cyclohexane with Molecular Oxygen (2009) (30)
Cyclometalated iridium(III) complexes with imidazo[4,5-f][1,10]phenanthroline derivatives for mitochondrial imaging in living cells. (2015) (30)
Recent advances in ruthenium(II) and iridium(III) complexes containing nanosystems for cancer treatment and bioimaging (2021) (30)
Rational Design of Cyclometalated Iridium(III) Complexes for Three-Photon Phosphorescence Bioimaging. (2020) (30)
Recent advances in lysosome-targeting luminescent transition metal complexes (2019) (30)
Synthesis, Characterization, and Photocatalytic Activity of TiO2 Microspheres Functionalized with Porphyrin (2012) (30)
A comparative study of the interaction of two structurally analogous ruthenium complexes with human telomeric G-quadruplex DNA. (2013) (29)
The production of glucose oxidase using the waste myceliums of Aspergillus niger and the effects of metal ions on the activity of glucose oxidase (1996) (29)
Cancer-specific chemotherapeutic strategy based on the vitamin K3 mediated ROS regenerative feedback and visualized drug release in vivo. (2018) (29)
DNA-binding and cleavage studies of a dinuclear copper(II) complex with a 26-membered hexaazamacrocycle (2002) (28)
Ambivalent metal ion binding properties of cytidine in aqueous solution (1992) (28)
Unexpected phosphodiesterase activity at low pH of a dinuclear copper-β-cyclodextrin complex. (2011) (28)
A ruthenium(II) β-carboline complex induced p53-mediated apoptosis in cancer cells. (2013) (28)
Assembly chemistry of a cadmium(II) complex with cyanometalate anions [Fe(CN)5NO]2−, [Pd(CN)4]2− and [Pt(CN)6]2− (2002) (28)
β-Cyclodextrin/glycyrrhizic acid functionalised quantum dots selectively enter hepatic cells and induce apoptosis. (2012) (28)
Syntheses, characterization and third-order nonlinear optical properties of ruthenium(II) complexes containing 2-phenylimidazo-[4,5-f][1,10]phenanthroline and extended diimine ligands (2001) (27)
Effect of hydrophobic interaction cooperating with double Lewis acid activation in a zinc(II) phosphodiesterase mimic. (2010) (27)
Syntheses, spectra and crystal structures of ruthenium(II) complexes with polypyridyl: [Ru(bipy)2(phen)](ClO4)2 · H2O and [Ru(bipy)2(Me-phen)](ClO4)2☆ (1995) (27)
Molecular recognition of amino acid esters by porphyrinatozinc(II): observation of a new binding mode (2000) (27)
Synthesis, characterization and in vitro and in vivo photodynamic activities of a gallium(iii) tris(ethoxycarbonyl)corrole. (2017) (27)
Silica microspheres functionalized with porphyrin as a reusable and efficient catalyst for the photooxidation of 1,5-dihydroxynaphthalene in aerated aqueous solution (2009) (27)
DNA Interactions of a Dinuclear Ruthenium(II) Complex Bridged by 1,3-bis(1,10-phenanthroline[5,6-d]imidazol-2-yl)benzene (2006) (26)
A mitochondria-targeting photothermogenic nanozyme for MRI-guided mild photothermal therapy. (2018) (26)
Stabilization of human telomeric G-quadruplex and inhibition of telomerase activity by propeller-shaped trinuclear Pt(II) complexes. (2014) (26)
Synthesis, characterization, and DNA-binding properties of the ruthenium(II) complexes [Ru(dipn)(dptp)](ClO4)2 and [Ru(dipn)(pat)](ClO4)2 (dipn =N-(3-aminpropyl)propane-1,3-diamine; dptp = 2-(5,6-diphenyl-1,2,4-triazin-3-yl)-1,10-phenanthroline; pat = 9-(1,10-phenanthrolin-2-yl)acenaphtho[1,2-e][1,2 (2004) (26)
Single oxygen-mediated DNA photocleavage of a di-bithiazolyl ruthenium(II) complex [Ru(btz) 2 (dppz)] 2+ (2008) (26)
[NiL]2[Fe(CN)6]·4H2O [L = 3,10-bis(2-hydroxyethyl)-1,3,5,8,10,12-hexaazacyclotetradecane]: a novel three-dimensional iron(II)–nickel(II) cyanide-bridged bimetallic assembly with a vat-like structure (2001) (26)
-Recoding Cancer Epigenome by Intervening Metabolism and Iron Homeostasis with Mitochondria-Targeted Re(I) Complexes. (2020) (26)
Platinum(II) clovers targeting G-quadruplexes and their anticancer activities. (2015) (26)
Necroptosis Induced by Ruthenium(II) Complexes as Dual Catalytic Inhibitors of Topoisomerase I/II. (2020) (26)
A mitochondria-targeting dinuclear Ir-Ru complex as a synergistic photoactivated chemotherapy and photodynamic therapy agent against cisplatin-resistant tumour cells. (2019) (25)
A Lysosome-Targeting Iridium(III) Probe with Near-Infrared Emission for The Visualization of NO/O2•- Crosstalk via in vivo Peroxynitrite Imaging. (2020) (25)
The catalysis of some novel polystyrene-supported porphyrinatomanganese(III) in hydroxylation of cyclohexane with molecular oxygen (2001) (25)
Functions and applications of polypyridyl complexes in DNA (2001) (25)
γ-Cyclodextrin–folate complex-functionalized quantum dots for tumor-targeting and site-specific labeling (2011) (25)
Tumor-targeted supramolecular nanoparticles self-assembled from a ruthenium-β-cyclodextrin complex and an adamantane-functionalized peptide. (2017) (25)
Mitochondria-specific imaging and tracking in living cells with two-photon phosphorescent iridium(iii) complexes. (2015) (25)
Ruthenium(II) complexes containing novel asymmetric tridentate ligands: synthesis, structure, electrochemical and spectroscopic properties (2001) (25)
[NiL1]3[Cr(CN)6]2·18H2O [L1 = 3,10-bis(2-hydroxyethyl)-1,3,5,8,10,12-hexaazacyclotetradecane]: a two-dimensional bimetallic assembly exhibiting antiferromagnetic ordering and metamagnetic behavior (2001) (25)
Synthesis, characterization, and DNA-binding studies of ruthenium complexes [Ru(tpy)(ptn)]2+ and Ru(dmtpy)(ptn)]2+. (2012) (24)
Cyclometalated iridium(III) complexes as mitochondria-targeted anticancer agents. (2016) (24)
Aggregation-induced emission of ruthenium(II) polypyridyl complex [Ru(bpy)2(pzta)]2+ (2010) (24)
Photodamaging of Mitochondrial DNA to Overcome Cisplatin Resistance by a RuII -PtII Bimetallic Complex. (2018) (24)
Synthesis and spectroscopic RNA binding studies of [Ru(phen)2MHPIP]2+ (2003) (24)
Ruthenium(II) complexes coordinated to graphitic carbon nitride: Oxygen self-sufficient photosensitizers which produce multiple ROS for photodynamic therapy in hypoxia. (2021) (24)
DNA cleavage mediated by water-soluble manganese corrole (2011) (24)
Photodegradation of 1,5-dihydroxynaphthalene catalyzed by meso-tetra(4-sulfonatophenyl)porphyrin in aerated aqueous solution (2008) (24)
Synthesis, DNA‐Binding and Photocleavage Studies of the Ruthenium(II) Complexes [Ru(phen)2(ppd)]2+ and [Ru(phen)(ppd)2]2+ (ppd=Pteridino[6,7‐f] [1,10]phenanthroline‐11,13(10H,12H)‐dione, phen=1,10‐Phenanthroline) (2008) (23)
Synthesis, photophysical and anticancer properties of mitochondria-targeted phosphorescent cyclometalated iridium(III) N-heterocyclic carbene complexes. (2019) (23)
A dendritic nano-sized hexanuclear ruthenium(II) complex as a one- and two-photon luminescent tracking non-viral gene vector (2015) (23)
Three-in-One Self-Assembled Nanocarrier for Dual-Drug Delivery, Two-Photon Imaging, and Chemo-Photodynamic Synergistic Therapy. (2018) (23)
Labile ruthenium(ii) complexes with extended phenyl-substituted terpyridyl ligands: synthesis, aquation and anticancer evaluation. (2015) (23)
Synthesis, Characterization, and DNA Interaction Studies of the Ruthenium(II) Complexes [Ru(bpy)2(ipbp)]2+ and [Ru(ipbp)(phen)2]2+ (ipbp=3‐(1H‐Imidazo[4,5‐f][1,10]phenanthrolin‐2‐yl)‐4H‐1‐benzopyran‐2‐one; bpy=2,2′‐Bipyridine; phen=1,10‐Phenanthroline) (2004) (23)
Ruthenium(II) complexes containing asymmetric 2-(pyrazin-2-yl)naphthoimidazole: syntheses, characterization, DNA-binding and photocleavage studies (2005) (23)
An effective metallohydrolase model with a supramolecular environment: structures, properties, and activities. (2007) (23)
Ester hydrolysis by a cyclodextrin dimer catalyst with a tridentate N,N',N''-zinc linking group. (2009) (23)
Lipophilic phosphorescent iridium(III) complexes as one- and two-photon selective bioprobes for lipid droplets imaging in living cells (2018) (23)
Purification, kinetic and thermodynamic studies of a new ribonuclease from a mutant of Aspergillus niger. (2005) (23)
Multifunctional mesoporous silica nanoparticles as efficient transporters of doxorubicin and chlorin e6 for chemo-photodynamic combinatorial cancer therapy (2018) (23)
Dinuclear iridium(iii) complexes as phosphorescent trackers to monitor mitochondrial dynamics. (2015) (23)
Mitochondrial Dynamics Tracking with Two-Photon Phosphorescent Terpyridyl Iridium(III) Complexes (2016) (22)
Synthesis, biocompatibility and luminescence properties of quantum dots conjugated with amino acid-functionalized β-cyclodextrin (2012) (22)
Syntheses and carbon monoxide substitution reactions of η5-N-heterocycle manganese tricarbonyls (1985) (22)
A mitochondria-targeting hetero-binuclear Ir(iii)-Pt(ii) complex induces necrosis in cisplatin-resistant tumor cells. (2018) (22)
pH responsive luminescent switches of ruthenium(II) complexes containing two imidazole groups: Synthesis, spectroscopy, electrochemistry and theoretical calculations (2009) (22)
Synthesis, characterization, and DNA-binding of chiral complexes delta- and lambda-[Ru(bpy)2(pyip)]2+. (2009) (22)
Effective combination treatment of lung cancer cells by single vehicular delivery of siRNA and different anticancer drugs (2016) (21)
CAIXplatins: highly potent Pt(IV) prodrugs selectively against hypoxic tumors via microenvironment and metabolism regulation. (2020) (21)
Mono-, di-, and tetranuclear ruthenium(II) complexes containing 3-(pyridin-2-yl)-as-triazino[5,6-f]1,10-phenanthroline: synthesis, characterization, and electrochemical and photophysical properties. (2003) (21)
Tracking mitochondrial pH fluctuation during cell apoptosis with two-photon phosphorescent iridium(iii) complexes. (2018) (21)
Fluorinated cyclometalated iridium(iii) complexes as mitochondria-targeted theranostic anticancer agents. (2017) (21)
Studies on thermodynamic nature of steroselectivity for ruthenium(II) polypyridyl complex binding to DNA (2010) (21)
Syntheses, crystal structures and spectroscopic characterization of [Co(phen)2(gly)]Cl2.4H2O and [Co(phen)2(H2O)2](NO3)3.2H2O (1994) (21)
DNA-binding and photocleavage studies of cobalt(III) polypyridyl complexes:. (2001) (21)
Nucleus-targeting ultrasmall ruthenium(iv) oxide nanoparticles for photoacoustic imaging and low-temperature photothermal therapy in the NIR-II window. (2020) (21)
Synthesis, Characterization, and DNA‐Binding Properties of the Chiral Ruthenium(II) Complexes Δ‐ and Λ‐[Ru(bpy)2(dmppd)]2+ (dmppd = 10,12‐Dimethylpteridino[6,7‐f] [1,10]phenanthroline‐11,13(10H,12H)‐dione; bpy = 2,2′‐Bipyridine) (2007) (20)
Thermostability, solvent tolerance, catalytic activity and conformation of cofactor modified horseradish peroxidase. (2008) (20)
Synthesis, characterization and DNA-binding studies of chiral ruthenium(II) complexes with 2-(5-nitrofuran-2-yl)-1H-imidazo[4,5-f][1,10]phenanthroline (2010) (20)
Novel ruthenium(II) polypyridyl complexes as G-quadruplex stabilisers and telomerase inhibitors. (2014) (20)
Effects of intercalative ligands on the DNA binding, DNA topoisomerase II and DNA transcription inhibition of polypyridyl ruthenium(II) complexes (2011) (20)
Theoretical and experimental studies on electron transfer among complexes [M(phen)3]2+ [M=Os(II), Ru(II), Co(III) and Zn(II)] binding to DNA (2003) (20)
Photodecaging of a Mitochondria-Localized Iridium(III) Endoperoxide Complex for Two-Photon Photoactivated Therapy under Hypoxia. (2022) (20)
Fabrication of red blood cell membrane-camouflaged Cu2-xSe nanoparticles for phototherapy in the second near-infrared window. (2019) (20)
A biotinylated ruthenium(ii) photosensitizer for tumor-targeted two-photon photodynamic therapy. (2019) (20)
Electrochemistry of a novel monoruthenated porphyrin and its interaction with DNA (2007) (20)
Cationic porphyrin–anthraquinone dyads: Modes of interaction with G-quadruplex DNA (2009) (20)
Theranostic TEMPO-functionalized Ru(ii) complexes as photosensitizers and oxidative stress indicators. (2017) (20)
Phosphorescent metal complexes as theranostic anticancer agents: combining imaging and therapy in a single molecule (2021) (20)
[Ru(bpy)2(pipdpa)]2+ as a highly sensitive and selective luminescent chemosensor for Cu2+ in aqueous solution (2012) (20)
Quantitative Detection of G‐Quadruplex DNA in Live Cells Based on Photon Counts and Complex Structure Discrimination (2020) (19)
Hydroxylation of cyclohexane catalyzed by porphyrinatoiron(III) with molecular oxygen: the effect of the photochemical stability of porphyrinatoiron(III) in various solvents (2000) (19)
Precisely-assembled Nanoparticles Against Cisplatin-Resistance via Cancer-specific Targeting of Mitochondria and Imaging Guided Chemo-Photothermal Therapy. (2020) (19)
Oligocyanometallic cords as building blocks in luminescent three-dimensional coordination polymers: [Ag4Cd2(tren)2(CN)6.5] [Ag(CN)1.5] and [Au2Cd(tren)(CN)4] · H2O (2002) (19)
Label-free fluorescent DNA biosensors based on metallointercalators and nanomaterials. (2013) (19)
Cyclometalated IrIII Complexes as Mitochondria‐Targeted Photodynamic Anticancer Agents (2017) (19)
DNA binding and nuclease activity of a water-soluble sulfonated manganese(III) corrole (2013) (19)
Charge-driven tripod somersault on DNA for ratiometric fluorescence imaging of small molecules in the nucleus (2019) (19)
Stability of ternary metal ion complexes formed by imidazole and the anion of N,N-bis(2-hydroxyethyl)glycine (Bicine). Observation of a relatively high stability of the Zn(Bicinate)(imidazole)+ complex (1993) (18)
Synthesis, structure and DNA-binding studies on the 2-(3-chlorophenyl)imidazo[4,5-f]1,10-phenanthroline-bis(2,2′-bipy ridine)-ruthenium(II) complex (1999) (18)
Anticancer IrIII -Aspirin Conjugates for Enhanced Metabolic Immuno-Modulation and Mitochondrial Lifetime Imaging. (2019) (18)
Synthesis, characterization and DNA-binding properties of mixed porphyrin–polypyridyl ruthenium(II) complexes (2005) (18)
Synthesis, DNA-binding and photocleavage studies of cobalt(III) complexes [Co(bpy)2(dpta)]3+ and [Co(bpy)2(amtp)]3+ (2007) (18)
Mercury(II) promotes the in vitro aggregation of tau fragment corresponding to the second repeat of microtubule-binding domain: Coordination and conformational transition. (2010) (18)
Binding to DNA purine base and structure-activity relationship of a series of structurally related Ru(II) antitumor complexes: a theoretical study. (2008) (18)
Photophysical properties of the Corrole photosensitizers (2010) (18)
A novel μ3-cyano-bridged heterotrimetallic 2-D coordination polymer constructed from rectangular grids (2000) (18)
Synthesis, DNA-binding and spectral properties of novel complexes [RuL2(idpq)]2+ (L = bpy, phen) with embedded CO (2009) (17)
Structure, speciation, DNA binding and nuclease activity of two bipyridyl-zinc complexes bearing trimethylaminomethyl groups (2009) (17)
Effect of cyclodextrin dimers with bipyridyl and biphenyl linking groups on carboxyl ester hydrolysis catalyzed by zinc complex (2009) (17)
StructureActivity Relationship of Polypyridyl Ruthenium(II) Complexes as DNA Intercalators, DNA Photocleavage Reagents, and DNA Topoisomerase and RNA Polymerase Inhibitors (2013) (17)
Mitochondria-targeting cyclometalated iridium(iii) complexes for tumor hypoxic imaging and therapy (2019) (17)
Folate receptor-targeted theranostic IrSx nanoparticles for multimodal imaging-guided combined chemo-photothermal therapy. (2018) (17)
A self-assessed photosensitizer: inducing and dual-modal phosphorescence imaging of mitochondria oxidative stress. (2018) (17)
Synthesis of phenothiazine-corrole dyads: the enhanced DNA photocleavage properties (2010) (17)
Trinuclear Ru(II) polypyridyl complexes as human telomeric quadruplex DNA stabilizers (2010) (17)
DNA-promoted electrochemical assembly of [Ru(bpy)2IP]3+/2+ at an ITO electrode (2006) (17)
DFT/TDDFT studies on electronic absorption and emission spectra of [Ru(bpy)2(L)]2+ (L = pip, o-mopip and p-mopip) in aqueous solution (2008) (17)
Topoisomerase IIα poisoning and DNA double-strand breaking by chiral ruthenium(ii) complexes containing 2-furanyl-imidazo[4,5-f][1,10]phenanthroline derivatives. (2016) (17)
V-Shaped Dinuclear Pt(II) Complexes: Selective Interaction with Human Telomeric G-quadruplex and Significant Inhibition towards Telomerase (2013) (17)
Design of ruthenium-albumin hydrogel for cancer therapeutics and luminescent imaging. (2019) (17)
Binding of novel octahedral metal complexes to DNA (1997) (17)
Hydroxylation of cyclohexane catalyzed by iron(III)—metal-free porphyrin dimer with molecular oxygen: The effect of the steric hindrance and the intramolecular interaction between the two prophyrin rings (1996) (17)
DNA/HSA interaction and nuclease activity of an iron(III) amphiphilic sulfonated corrole. (2015) (17)
Genomic and transcriptional changes in response to pinene tolerance and overproduction in evolved Escherichia coli (2019) (17)
Molecular architecture via coordination and multi-intermolecular interactions: Synthesis, structures and magnetic properties of one-dimensional coordination polymers of macrocyclic nickel(II) complexes with terephthalate and trans-butene dicarboxylate (2003) (16)
Hydrogen bond induced change of geometry and crystallized form of copper(II) complexes: syntheses and crystal structure of complexes with Schiff-base ligands containing two imidazolyl groups (2001) (16)
Colorimetric and luminescent dual-signaling responsive probing of thiols by a ruthenium(II)-azo complex. (2013) (16)
Ruthenium(II) Complexes with Dppz: From Molecular Photoswitch to Biological Applications (2016) (16)
Spectroscopic properties of p/p and o/o type iron(III)‐metal‐free porphyrin dimers and their catalysis as Cytochrome P450 model (2001) (16)
DNA Binding and Oxidative Cleavage by a Water‐soluble Carboxyl Manganese(III) Corrole (2013) (16)
Boosting two-photon photodynamic therapy with mitochondria-targeting ruthenium-glucose conjugates. (2020) (16)
Iridium(iii) complexes with five-membered heterocyclic ligands for combined photodynamic therapy and photoactivated chemotherapy. (2017) (16)
Boosting the sensitivity of pH responsible luminescent switches of polypyridyl ruthenium(II) complexes by structural design (2012) (16)
The hydrolysis process of the anticancer complex [ImH][trans-RuCl4(Im)2]: a theoretical study. (2007) (16)
Stacking interaction in metal complexes with compositions of DNA and heteroaromatic N-bases (2002) (16)
The heavy atom effect on photocleavage of DNA by mono-hydroxyl halogenated corroles (2010) (16)
Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties (2020) (16)
Alkynyl corroles: synthesis by Sonogashira coupling reaction and the physicochemical properties (2010) (16)
DFT studies on the molecular orbitals and related properties of [Ru(phen)2(9,9′-2R-dpq)]2+(R=NH2,OH,H and F) (2003) (15)
DNA structure, binding mechanism and biology functions of polypyridyl complexes in biomedicine (2001) (15)
Hydroxylation of cyclohexane catalyzed by iron(III)-iron(III) porphyrin dimers and DABCO with molecular oxygen : evidence for the conformation effect of porphyrin dimers on the catalytic activity (1999) (15)
In vitro and in vivo investigations on the antiviral activity of a series of mixed-valence rare earth borotungstate heteropoly blues. (2008) (15)
Rapid hydrolysis of phosphate ester promoted by Ce(IV) conjugating with a β-cyclodextrin monomer and dimer. (2012) (15)
Syntheses and structures of μ-[N,N′-bis(2-aminoethyl)-1,2-ethanediamine-N1,N1′,N2,N2′]-bis[N,N′-(bis(2-aminoethyl)-1,2-ethanediamine-N,N′,N″,N‴)]dinickel(II) perchlorate and 4,4′-biphenyldisulfonate (2001) (15)
A Platinum(II)-based Photosensitive Tripod as an Effective Photodynamic Anticancer Agent through DNA Damage. (2017) (15)
CHIRAL LINEAR ASSEMBLY OF AMINO ACID BRIDGED DIMERIC PORPHYRIN HOSTS (1997) (15)
Synthesis, characterization and third-order nonlinear optical properties of ruthenium(II) complexes containing 2-(4-nitrophenyl)imidazo[4,5-f] [1,10]phenanthroline (2004) (15)
Self-assembly of copper and magnesium ions will l-glutamate: spectroscopic and structural properties of [CuMg(L-GLUTAMATO)2(H2O)3]·2H2O (1998) (15)
Synthesis, structure and magnetism of a μ3-carbonato bridged nickel(II) complex with 2,2′,2″-tris(2-aminoethyl)amine ligand: a new coordination mode of carbonato bridge (2004) (15)
Solid and solution studies of ternary copper(II) complexes formed by heteroaromatic N bases and the anion of N , N -bis(2-hydroxyethyl)glycine (bicine) (1999) (15)
Synthesis, DNA-binding and photocleavage studies of cobalt(III) mixed-ligand complexes (2002) (14)
Supramolecular Assembly of An Organoplatinum(II) Complex with Ratiometric Dual Emission for Two-Photon Bioimaging. (2020) (14)
Antiviral Activity of Mixed-Valence Rare Earth Borotungstate Heteropoly Blues against Influenza Virus in Mice (2000) (14)
Synthesis, crystal structures and properties of copper(II) complexes of Schiff base derivatives containing imidazole and β-alanine groups (1999) (14)
The synthesis, characterization and crystal structure of trans(N)-(1,10-phenanthroline)-bis(L-prolinato)cobalt(III) perchlorate hydrate (1993) (14)
Electronic and fluorescence spectral studies of a novel porphyrin-polypyridyl ruthenium(II) hybrid linked by a butyl chain. (2007) (14)
Ruthenium(II) complexes of 2-phenylimidazo[4,5-f] [1,10]phenanthroline. Synthesis, characterization and third order nonlinear optical properties (2002) (14)
DNA affinity and cleavage by naphthalene-based mononuclear and dinuclear copper(II) complexes (2009) (14)
The preparation of some polystyrene-supported porphyrinatoiron(III) and their catalysis in hydroxylation of cyclohexane with molecular oxygen (1996) (14)
Photodynamic Therapy Activities of 10‐(4‐Formylphenyl)‐5,15‐bis(pentafluorophenyl)corrole and Its Gallium Complex (2017) (14)
Enantioselective Hydrolysis of Amino Acid Esters Promoted by Bis(β-cyclodextrin) Copper Complexes (2016) (14)
The stepwise photodamage of organelles by two-photon luminescent ruthenium(ii) photosensitizers. (2019) (14)
Cationic pyridinium porphyrins appending different peripheral substituents: spectroscopic studies on their interactions with bovine serum albumin. (2012) (14)
Mitochondrial DNA targeting and impairment by a dinuclear Ir–Pt complex that overcomes cisplatin resistance (2020) (14)
Bimodal Visualization of Endogenous Nitric Oxide in Lysosomes with A Two-Photon Iridium(III) Phosphorescent Probe. (2019) (14)
A Biodegradable Iridium(III) Coordination Polymer for Enhanced Two-Photon Photodynamic Therapy Using an Apoptosis-Ferroptosis Hybrid Pathway. (2022) (14)
Enantioselective binding of Λ- and Δ-[Ru(bpy)2(HPIP)]Cl2 (HPIP=2-(2-hydroxyphenyl)imidazo[4,5-f][1,10]phenanthroline) to the hexanucleotide [d(5′-GTCGAC-3′)2] (2003) (13)
Enhancing the photothermal stability and photothermal efficacy of AuNRs and AuNTs by grafting with Ru(ii) complexes. (2017) (13)
Trigeminal star-like platinum complexes induce cancer cell senescence through quadruplex-mediated telomere dysfunction. (2016) (13)
Tris(1,10-phenanthroline)iron(II) diperchlorate hemihydrate (1994) (13)
Multiaction Platinum(IV) Prodrug Containing Thymidylate Synthase Inhibitor and Metabolic Modifier against Triple-Negative Breast Cancer. (2020) (13)
Styrene–hydroxyethyl methacrylate copolymer microsphere immobilized porphyrinatomanganese(III) as a mild, reusable and highly efficient catalyst for epoxidation of cyclohexene with molecular oxygen (2010) (13)
SYNTHESES AND CHARACTERIZATION OF SOME PORPHYRINS AND METALLOPORPHYRINS (1990) (13)
Synthesis, characterization and DNA-binding and DNA-photocleavage studies of two Ru(II) complexes containing two main ligands and one ancillary ligand (2011) (13)
Aquation and dimerization of osmium(II) anticancer complexes: a density functional theory study (2012) (13)
Phosphorescent Iridium(III) Complexes for Anticancer Applications (2020) (13)
Enhanced production of pinene by using a cell-free system with modular cocatalysis. (2020) (13)
The synthesis and spectroscopic characterization of a chiral zinc(II) porphyrin dimer containing an amino acid bridge: model complexes for the induced circular dichroism of porphyrin protein supramolecules (1998) (13)
Stability of some metal-ion complexes of tubercidin (= 7-deazaadenosine) in aqueous solution. An o-amino group inhibits complexation at N1 of purines! (1991) (13)
Structure of [Ru(phen)3](ClO4)2.(C2H5)2O (2001) (12)
DNA Interactions of the Functionalized (Mixed Polypyridine)ruthenium(II) Complex Bis(2,2′‐bipyridine‐κN1,κN1′)(methyl dipyrido[3,2‐a : 2′,3′‐c]phenazine‐11‐carboxylate‐κN4,κN5)ruthenium(2+) ([Ru(bpy)2(dppz‐11‐CO2Me)]2+) (2008) (12)
Electronic structures, DNA-binding and spectral properties of Co(III) complexes [Co(bpy)2(L)]3+ (L=pip, odhip, hnoip). (2009) (12)
Rational design of a lysosome-targeting and near-infrared absorbing Ru(II)-BODIPY conjugate for photodynamic therapy. (2021) (12)
Metal complexes for mitochondrial bioimaging. (2019) (12)
Carboxylic ester hydrolysis catalyzed by a host-guest system constructed by cyclodextrin dimer and zinc complex (2008) (12)
[Ru(bpy)2(bppp)]2 + binds two different forms of the human telomeric G-quadruplex structure (2012) (12)
A two-dimensional coordination polymer with a brick wall structure and hydrophobic channels: synthesis and structure of a macrocyclic nickel(II) complex with 1,3,5-benzenetricarboxylate (2001) (12)
Synthesis, characterization and interaction with DNA of ruthenium(II) mixed-ligand complexes containing pyridino[3,2-f] [1,7]phenanthroline (1996) (12)
Efficient promotion of phosphate diester cleavage by a face-to-face cyclodextrin dimer without metal. (2012) (12)
Synthesis, crystal structures, DNA binding and oxidative cleavage studies of copper(II) complexes of N2S2 tetradentate ligands (2009) (12)
Tetranuclear ruthenium(II) complexes with oligo-oxyethylene linkers as one- and two-photon luminescent tracking non-viral gene vectors. (2015) (12)
DNA binding and nuclease activity of cationic iron(IV) and manganese(III) corrole complexes (2014) (12)
Crystal Structure Investigation of 2‐Pheny limidazo [f]1,10‐phenanthroline (1996) (12)
Synthesis, crystal structure and DNA-binding studies of a Ru(II) complex containing two main ligands (2008) (12)
Carboxylate shift in one dimension polymeric chain complexes [Cu (dien) (OAc) ] n (ClO4) n. Syntheses, crystal structure and spectroscopic study on isomer (1998) (12)
Selectivity and Targeting of G-quadruplex Binders Activated by Adaptive Binding and Controlled by Chemical Kinetics. (2021) (12)
A novel dinuclear zinc complex containing both imidazole and carboxylate groups as a possible model for serine/threonine protein phosphatase-1 (2000) (11)
Mitochondria-targeted Ir@AuNRs as bifunctional therapeutic agents for hypoxia imaging and photothermal therapy. (2019) (11)
Interactions of polypyridyl cobalt complexes with DNA studied by rotating electrode methods (2005) (11)
Phosphate ester hydrolysis catalyzed by a dinuclear cobalt(II) complex equipped with intramolecular β-cyclodextrins (2015) (11)
DNA cleavage by a novel acyclic copper(II) complex (2004) (11)
Ester catalytic hydrolysis by a tridentate N,N',N''-copper bridged cyclodextrin dimer (2011) (11)
Selective binding and reverse transcription inhibition of single-strand poly(A) RNA by metal TMPyP complexes. (2014) (11)
Mechanism of aquation and nucleobase binding of ruthenium (II) and osmium (II) arene complexes: A systematic comparison DFT study (2012) (11)
Synthesis, Structures, and Crystalline Packing Features of [Co(tren)(amino acidato-N,O)]X2·nH2O (X = ClO4−, I−) (2000) (11)
Synthesis, characterization and crystal structure of ruthenium(II) polypyridyl complexes (1999) (11)
Three‐Dimensional Structure Constructed via Hydrogen Bonds and π‐π Stacking Interaction. Crystal Structure of [Cu(AFO)2(H2O)2](ClO4)2.2(AFO).2H2O (AFO = 4,5‐Diazafluoren‐9‐one) (2000) (11)
DNA-binding, photocleavage and anti-cancer activity of tin(IV) corrole (2018) (11)
Synthesis, characterization, and crystal structure of a functionalized ruthenium(II) polypyridyl complex with fused triazinone as ligand. (2001) (11)
Synthesis, crystal structure, DNA binding, and oxidative cleavage activity of copper(II)-bipyridyl complexes containing tetraalkylammonium groups (2009) (11)
Molecular stereochemistry of μ-oxo-bis[5,10,15,20-tetra(4-chlorophenyl)-porphinatoiron(III)]—A model compound of cytochrome P450 (1997) (11)
Synthesis and spectroscopic DNA binding studies of homoleptic and heteroleptic ruthenium(II) complexes with imidazo[4,5-f] [1,10]phenanthroline or its derivatives (1999) (11)
Investigation of Excited-State Photophysical Properties of Water-Soluble Gallium Corrole (2017) (10)
Experimental and Theoretical Studies on DNA-Binding and Spectral Properties of'Light Switch' Complexes [Ru(L)2(ppn)]2+ (L=2,2'-Bipyridine and 1,10-Phenanthroline; ppn =Pteridino[6,7-f] [1,10]phenanthroline-11,13-diamine) (2008) (10)
Synthesis and catalytic activities in cyclohexane hydroxylation of metalloporphyrins supported on styrene-methylacrylic acid copolymer microspheres (2008) (10)
Mitochondria-Targeting and Reversible Near-Infrared Emissive Iridium(III) Probe for in vivo ONOO-/GSH Redox Cycles Monitoring. (2021) (10)
Studies of molecular recognition mechanism in supramolecular system of ruthenium(II) polypyridyl complexes and DNA (1999) (10)
Activity, stability, and unfolding of reconstituted horseradish peroxidase with modified heme (2009) (10)
Synthesis, characterization, electrochemical and photophysical properties of ruthenium(II) complexes containing 3-amino-1,2,4-triazino[5,6-f]-1,10-phenanthroline (2008) (10)
A theoretical study on the hydrolysis process of two Keppler-type antitumor complexes [TzH][trans-RuCl4(Tz)2] and [2-NH2TzH][trans-RuCl4(2-NH2Tz)2]. (2009) (10)
Anti-metastasis and anti-proliferation effect of mitochondria-accumulating ruthenium(II) complexes via redox homeostasis disturbance and energy depletion. (2021) (10)
Synthesis, structures and hydrolytic properties of metal complexes with 1,3-bis (4-methyl-5-imidazol-1-yl)ethylideneamino propan-2-ol (1999) (10)
Temperature dependence of dual emission in ruthenium(II) complexes containing 3,3′-bi-1,2,4-triazine derivatives (2010) (10)
A Nitroxide-Tagged Platinum(II) Complex Enables the Identification of DNA G-Quadruplex Binding Mode. (2016) (10)
DNA intercalating studies of [Ru(bpy)2HPIP]2+ with intramolecular hydrogen bond ligand based on introduction of copper ion (2007) (10)
An ER‐Targeting Iridium(III) Complex That Induces Immunogenic Cell Death in Non‐Small‐Cell Lung Cancer (2021) (10)
Photoinduced Electron Transfer between Anionic Corrole and DNA. (2016) (10)
Complexation of cobalt(II) perchlorate with crown ethers. Synthesis, properties and structure of complexes of cobalt(II) perchlorate with 16-crown-5 and its lariat derivatives (1999) (9)
Cooperative folding of tau peptide by coordination of group IIB metal cations during heparin-induced aggregation (2012) (9)
The magnetic properties, DNA/HSA binding and nuclease activity of manganese N-confused porphyrin (2016) (9)
Assembly of tris(2-aminoethyl)amines and its unusual conversion by silver(I) ions (2001) (9)
Traceable in-cell synthesis and cytoplasm-to-nucleus translocation of a zinc Schiff base complex as a simple and economical anticancer strategy. (2019) (9)
Metal complexes of porphyrin–anthraquinone hybrids: DNA binding and photocleavage specificities (2011) (9)
Synthesis, characterization and visible-light photocatalytic activity of TiO2–SiO2 composite modified with zinc porphyrins (2012) (9)
Enhanced anti-cancer efficacy to cancer cells by doxorubicin loaded water-soluble amino acid-modified β-cyclodextrin platinum complexes. (2014) (9)
Synthesis, DNA-binding and DNA-photocleavage properties of ruthenium(II) mixed-polypyridyl complex [Ru(tbz)2(dppz)]2+ (2008) (9)
Synthesis, characterization and DNA-binding of novel chiral complexes delta- and lambda-[Ru(bpy)2L]2+ (L = o-mopip and p-mopip). (2006) (9)
A fluorescence study of tetraphenylporphyrinatozinc(II)/imidazolyl-linked porphyrinatoiron(III) systems. (2003) (9)
Nickel(II) complexes of amino acids in comparison with the cobalt(III) analogues: interesting structural aspects relative to intermolecular hydrogen bonds and chiral recognition (2002) (9)
Selection of biochemical mutants of Aspergillus niger with enhanced extracellular ribonuclease production (2004) (9)
A DFT study on the hydrolysis mechanism of the potential antitumor Ru(III) complex TzNAMI (2009) (9)
Molecular architecture via hydrophobic interaction. Synthesis and structure of [NiL](ClO4)2 ( L=3,10-bis(2-phenylethyl)-1,3,5,8,10,12-hexaazacyclotetradecane) (2000) (9)
Supramolecular self-assembly of porphyrin¿fluorescein hybrid with amino-porphyrinatocopper(II) and its fluorescence strengthening character (2004) (8)
Synthesis, Characterization, and DNA Binding Studies of Ruthenium(II) Complexes with 2-Pyridyl-1H-anthra(1,2-d)imidazole-6,11-dione (2008) (8)
Interfering with DNA High-Order Structures using Chiral Ruthenium(II) Complexes. (2018) (8)
Regulating Tumor N6 -Methyladenosine Methylation Landscape using Hypoxia-Modulating OsSx Nanoparticles. (2020) (8)
DNA-enhanced assembly of [Ru(bpy)2ITATP]3+/2+ on an ITO electrode (2007) (8)
Synthesis and crystal structures of ruthenium(II) complexes with polypyridyl: [Ru(bpy)2(AFO)](ClO4)2 · H2O and [Ru(dmp)2 (AFO)](ClO4)2 · 1/2DMF · 1/2MeCN (1998) (8)
Super-Resolution Tracking of Mitochondrial Dynamics with An Iridium(III) Luminophore (2018) (8)
Syntheses, characterization and DNA cleavage studies of acyclic copper(II) complexes (2004) (8)
Novel complexes of 5-(4-carboxyl)phenylene-methanaminophenyl-10,15,20-tri-phenylporphyrin with zinc(II), iron(III), manganese(III) and zinc(II)–iron(III), zinc(II)–manganese(III) supramolecular self-assembly by hydrogen bonding (2002) (8)
Stereoisomerically controlled supramolecular architectures: a new strategy for the construction of enantio- and diastereomerically pure multinuclear RuII complexes (2001) (8)
Mitochondria-targeting monofunctional platinum(ii)–lonidamine conjugates for cancer cell de-energization (2020) (8)
Synthesis, interaction with DNA and nuclease activity of zinc complexes of 2,2′-bipyridine derivatives with tetraalkylammonium groups (2009) (8)
Further study of the effect of macrocyclic pendant groups on the supramolecular architecture : Synthesis and structures of macrocyclic nickel (II) complexes with trans-butene dicarboxylate (2005) (8)
Dichlorobis(2-hydroxymethyl-1-methylimidazole-N3)zinc(II) (1999) (8)
[CuL(H2O)2]{[CuL][Fe(CN)6]}2·2H2O (L=3,10-Bis(2-hydroxyethyl)-1,3,5,8,10,12-hexaazacyclotetradecane): A Novel Three-Dimensional Coordination Polymer via H-Bonded Linkages of One-Dimensional Zigzag Chain (1999) (8)
Manganeseporphyrins immobilized on silica microspheres as biomimetic catalysts hydroxylating cyclohexane with molecular oxygen (2011) (8)
The synthesis of two novel hybrids containing a zinc(II) porphyrin unit and a polypyridyl ruthenium(II) complex unit and their photoinduced intramolecular electron and energy transfer (2008) (8)
Synthesis, crystal structure and anaerobic DNA photocleavage of ruthenium complexes [Ru(tpy)(dpoq)Cl](+) and [Ru(tpy)(dpoq)CH3CN](2.). (2015) (7)
Macrocyclic dinuclear copper(II) complex with a novel chloride bridged zigzag chain (2003) (7)
A carboxyl porphyrin zinc(II)–copper(II) supramolecular system with fluorescence strengthening properties (2003) (7)
Photophysical properties of free-base and manganese(iii) N-confused porphyrins. (2018) (7)
High nuclease activity of a copper(II)-bipyridyl complex containing cytosine pendants (2010) (7)
DNA interaction of ruthenium(ii) complexes with imidazo[4,5-f][1,10]phenanthroline derivatives. (2019) (7)
[Ru(tpy)(H4bbdip)]2+ as an anion-selective colorimetric sensor (2012) (7)
Correction: A self-assessed photosensitizer: inducing and dual-modal phosphorescence imaging of mitochondria oxidative stress. (2018) (7)
Autophagy-Dependent Apoptosis Induced by Apoferritin-Cu(II) Nanoparticles in Multidrug-Resistant Colon Cancer Cells. (2021) (7)
Bis ( 2 , 2 9-bipyridine ) ruthenium ( II ) complexes with imidazo (7)
Enantioselective hydrolysis of amino acid esters by non-chiral copper complexes equipped with bis (β-cyclodextrin)s (2016) (7)
Intramolecular aromatic-ring stacking interaction of ternary Zn(UTP)L2- complexes (1997) (6)
Styrene-hydroxyethyl methacrylate copolymer-supported porphyrinatomanganese(III) complexes: synthesis and catalytic cyclohexane hydroxylation with molecular oxygen (2010) (6)
An anthracene-modified β-cyclodextrin that distinguishes adenosine phosphates fluorescently (2014) (6)
FerriIridium: A Lysosome‐Targeting Iron(III)‐Activated Iridium(III) Prodrug for Chemotherapy in Gastric Cancer Cells (2019) (6)
Flavonoids Inhibit Heparin-Induced Aggregation of the Third Repeat (R3) of Microtubule-Binding Domain of Alzheimer's Tau Protein (2010) (6)
A structural change between the complexes of praseodymium and neodymium nitrates with (Z)-2,3-diphenyl-1,4,7,10, 13-pentaoxacyclo-pentadec-2-ene(stilbeno-15-crown-5): synthesis and structures of [Pr(NO3)3 (stilbeno-15-crown-5)] and [Nd(NO3)3 (EO5)] (EO5 tetraethyleneglycol) (1997) (6)
Structures of three cis-β1 and three cis-β2 isomers of [Co(trien)(aminoacidato)]2+ complexes (2001) (6)
Carboxy and diphosphate ester hydrolysis promoted by di- or tri-nuclear zinc(II) complexes based on β-cyclodextrin (2011) (6)
Experimental and Density-Functional-Theory (DFT) Studies on the DNA-Binding Trend and Spectral Properties of the Ruthenium Complexes [Ru(4,7-dmp)(bdip)]2+ and [Ru(bpy)2(bdip)]2+ (4,7-dmp=4,7-Dimethyl-1,10-phenanthroline, bdip=2-(1,3-Benzodioxol-4-yl)-1H-imidazo[4,5-f] [1,10]phenanthroline, bpy=2,2′- (2007) (6)
Ruthenium(II) complexes as bioorthogonal two-photon photosensitizers for tumour-specific photodynamic therapy against triple-negative breast cancer cells. (2021) (6)
Synthesis, Characterization, Electrochemical and Spectroscopic Properties of [Ru(dppt)(bpy)Cl]+ and [Ru(pta)(bpy)Cl]+ (2004) (6)
Synthesis, DNA-binding and photocleavage studies of ruthenium(II) complexes (Ru(btz) 3 ) 2+ and (Ru(btz)(dppz)2) 2+ (2009) (6)
Experimental and DFT Studies on the DNA-binding Properties of Ruthenium(II) Complexes [Ru(phen)2L]2+(L = o-MOP, o-MP, o-CP and o-NP) (2006) (6)
Synthesis, crystal structure and cyclic voltammetry of square- pyramidal acetatoaqua [(4-methylimidazol-5-yl)methylene] histamine copper(II) perchlorate (1999) (6)
Screening and Mutagenesis of Aspergillus niger for the Improvement of Glucose-6-Phosphate Dehydrogenase Production (2003) (6)
Synthesis, characterization and antiviral activity of nickel-substituted rare earth molybdosilicic heteropoly blues (2003) (6)
27Co Cobalt Complexes As Potential Pharmaceutical Agents (2005) (6)
Fabrication and characterizations of silica composite microspheres immobilized with porphyrins and their photocatalytic properties (2012) (6)
A novel porphyrin–polypyridyl ruthenium(II) hybrid. Synthesis, characterization and photoinduced DNA cleavage activity (2006) (6)
Crystal structure of [Cu4(pytp)2(SO4)2(H2O)10](SO4)2 · 4H2O. A tetranuclear copper(II) complex with a new asymmetric ligand, pytp*, as a bridge (2001) (6)
DNA-promoted electrochemical assembly of [Ru(bpy)2dpp]3+/2+ on the ITO electrode by introducing copper(II) ion (2008) (6)
A mitochondria-localized oxygen self-sufficient two-photon nano-photosensitizer for ferroptosis-boosted photodynamic therapy under hypoxia (2022) (6)
Chiral supramolecular assembly of amino acid bridged zinc bisporphyrin and bidentate ligand (1999) (5)
Effect of Electronic Structures of Enantiomers of Ruthenium(II) Polypyridyl Complexes on DNA Binding Behaviors (2010) (5)
Iridium(III) complexes as mitochondrial topoisomerase inhibitors against cisplatin-resistant cancer cells. (2021) (5)
Photodissociation of a ruthenium(II) arene complex and its subsequent interactions with biomolecules: a density functional theory study (2012) (5)
Investigation on DNA Binding and Photo-Cleavage Properties of Water-Soluble Porphyrin and Metalloporphyrins (2005) (5)
The self-aggregation of chiral threonine-linked porphyrins and their zinc(II) complexes (2000) (5)
The Impacts of Hg(II) Tightly Binding on the Alzheimer’s Tau Construct R3: Misfolding and Aggregation (2011) (5)
Magnetic field induced Freedericksz transition of a planar aligned liquid crystal doped with metalloporphyrins FeTPPCl, MnTPPCl and ZnTPP (2000) (5)
Necroptosis-inducing iridium(iii) complexes as regulators of cyclin-dependent kinases (2021) (5)
The photoinduced electron transference of porphyrin-anthraquinone dyads bridged with different lengths of links. (2011) (5)
Cyclometalated Iridium(III) Complexes as Mitochondria‐targeting Photosensitizers against Cisplatin‐resistant Cells † (2021) (5)
A novel fluorescein-porphyrinatozinc(II) hybrid: synthesis and its supramolecular self-assembly with imidazolyl-linked porphyrinatomanganese(III) by coordinative bonding (2005) (5)
Theoretical studies on DNA-binding, DNA-photocleavage and spectral properties of Co(III) complexes [Co(phen)2(L)]3+ (L = pip, hpip, hnaip) (2010) (5)
Nucleus-localized platinum(ii)–triphenylamine complexes as potent photodynamic anticancer agents (2019) (5)
Synthesis, characterization, electrochemistry and solvatochromic studies of [Ru(dppt)(dien)]2+ and [Ru(pta)(dien)]2+ (2004) (5)
A halogen ion-selective phosphorescence turn-on probe based on induction of Pt-Pt interactions. (2019) (5)
Recoding the Cancer Epigenome by Intervening in Metabolism and Iron Homeostasis with Mitochondria‐Targeted Rhenium(I) Complexes (2020) (5)
Synthesis, DNA binding and oxidative cleavage studies of an asymmetric tridentate copper(II) complex (2007) (5)
Studies of tailed metalloporphyrins VI. Synthesis, characterization and catalysis of benzimidazole-linked iron(III) porphyrins (1997) (4)
Calcium–nickel–lithium oxide: a high selectivity catalyst for the oxidative dehydrogenation of ethane to ethylene (1993) (4)
DNA-Binding and Photocleavage Behaviour of (Ru(bpy)2(MDPZ)) 2+ (2008) (4)
Synthesis, characterization and cytotoxic studies of diimine palladium(II) complexes with amino acids and their dithiocarbamate derivatives (1993) (4)
A DFT study on the hydrolysis mechanism of NH‐tautomeric antitumors of [HL][trans‐RuCl4L(dmso‐S)] (2009) (4)
A theoretical study on the substituent effect of DNA-photocleavage by [Ru(phen) 2(6-R-dppz)] 2+ (R = (2010) (4)
Conglomerate crystallization behavior of racemic [Co(N4)(aminoacidato)]2+ complexes (2001) (4)
Engineered exosomes as a natural nanoplatform for cancer targeted delivery of metal-based drugs (2021) (4)
Synthesis, characterization and anticancer mechanism studies of fluorinated cyclometalated ruthenium(ii) complexes. (2020) (4)
Effect of ancillary ligands on the electronic structures, DNA-binding and spectral properties of [Co(L)2(pip)]3+ (L = phen, bpy, en, tap) (2008) (4)
Nano-assembly of ruthenium(II) photosensitizers for endogenous glutathione depletion and enhanced two-photon photodynamic therapy. (2021) (3)
Structures and crystallization behavior of cis-α-[Co(trien)(NO2)2]·ClO4 (I), cis-β-[Co(trien)(NO2)2]Br·2H2O (II), and cis-β-[Co(trien)(NO2)2]·ClO3 (III) (2000) (3)
Bis(4,4′‐dimethyl‐2,2′‐bipyridine) ruthenium (II) Complexes Containing 2‐Arylimidazo‐ [4,5‐f] [1,10] phenanthroline: Syntheses, Characterization and Third‐order Nonlinear Optical Properties (2010) (3)
Catalytic studies of 2-benzthiazolethiol (BzTa)-linked manganese(III) and cobalt(II) porphyrin complexes (2000) (3)
Synthesis, Characterization and Third-Order Nonlinear Optical Properties of a Series of Ruthenium(II) Complexes Containing 2-Arylimidazo-[4,5- f ][1,10]Phenanthroline (2003) (3)
The effect of the perturbation of hydrogen bonding on the Zn(II) coordination geometry: synthesis and structure of Zn(BIP) (H2O)(2) (ClO4)(2) (BIP=1,3-bis (4-methyl-5-imidazol-1-yl)ethylideneamino propane) (1999) (3)
Rational Design of Cyclometalated Iridium(III) Complexes for Three‐Photon Phosphorescence Bioimaging (2020) (3)
Effect of intrachain rotation of porphyrin molecules on luminescence efficiency in two kinds of low-doped porphyrin side-chain polymer films (2007) (3)
trans-(DL-isoleucinato-N, O)[tris(2-aminoethyl)amine-κ4N]cobalt(III) diperchlorate (2001) (3)
Preliminary communication: Magnetic-field-induced Freedericksz transition of a planar aligned liquid crystal doped with porphyrinatozinc(II): influence of the substituent of the porphyrin ring (2000) (3)
Synthesis, Characterization and Molecular Structure of Ternary Cu(II) Complex with 1, 4, 8, 9‐Tetraazatriphenylene and L‐Phenylaninate (2010) (3)
Synthesis, crystal structure and properties of square-planar acetato{[(4-methylimidazol-5-yl)methylene]histamine} copper(II) perchlorate (1999) (3)
Synthesis and X-ray crystal structures of one-dimensional coordination polymers of macrocyclic copper(II) and nickel(II) complexes (2002) (3)
A Homeotropical Alignment Nematic Liquid Crystal Doped with FeTPPCI Will Dramatically Decrease the Critical Magnetic Field for the Bend Reorientation in a Static Magnetic Field (2000) (3)
Predicting the interactions of organometallic ruthenium ethylenediamine complexes with mononucleotides: insights from density functional theory (2012) (2)
Synthesis of Chiral Amino Acid-Linked Porphyrin Protein Supramolecular Complexes and Their Novel Induced Circular Dichroism (2000) (2)
A mitochondrion-targeted BODIPY-Ir(III) conjugate as a photoinduced ROS generator for the oxidative destruction of triple-negative breast cancer cells. (2021) (2)
Tracking mitochondrial dynamics during apoptosis with phosphorescent fluorinated iridium(iii) complexes. (2018) (2)
The electronic effect in supramolecular self-assembly of para-substituted tetraphenylporphyrinatozinc(II) with imidazolyl-linked porphyrinatomanganese(III) by coordinative bonding (2005) (2)
Bis(2,2′-bipyridine)[2-(2-pyridyl)-1H-benzimidazol-1-yl]ruthenium(II) perchlorate acetonitrile solvate monohydrate (2006) (2)
DNA molecular light switch and biosensors based on ruthenium(II) polypyridyl complexes (2014) (2)
The ternary metal mixed ligand complexes formed by benzimidazole and N,N-bis( 2-hydroxyethyl) glycine (1999) (2)
Cover Picture: Histone‐Deacetylase‐Targeted Fluorescent Ruthenium(II) Polypyridyl Complexes as Potent Anticancer Agents (Chem. Eur. J. 31/2013) (2013) (2)
Recent Progress in Photodynamic Immunotherapy with Metal-Based Photosensitizers. (2022) (2)
Synthesis, characterization of ruthenium (II) polypyridine complexes and interaction with DNA (1995) (2)
WITHDRAWN: A mathematical model for gluconic acid fermentation by Aspergillus niger (2002) (2)
SYNTHESIS, CHARACTERIZATION, AND CATALYTIC STUDIES OF NEW BENZIMIDAZOLE-, BENZTHIAZOLE-, AND BENZAZOLE-LINKED IRON(III) PORPHYRINS (2001) (2)
5,6‐Diphenyl‐3‐(pyrazin‐2‐yl)‐1,2,4‐triazine (2002) (2)
Photochemical reaction of Rh2(CO)4(μ-TPP)(TPP=tetraphenyl-porphyrinato) with pyridine (Py) in benzene. Generation of a mononuclear rhodium(II) porphyrin radical complex Rh(TPP)(Py) (1992) (2)
1,2-Bis[amino(pyrimidin-2-yl)methylene]hydrazine dihydrate (2007) (2)
Synthesis and Characterization of Thiacalix[4] arene Derivatives with Polymerisable Groups (2007) (2)
Optimization of culture conditions for the production of an extracellular ribonuclease by Aspergillus niger in a benchtop bioreactor (2004) (2)
Syntheses, crystal structures and properties of copper(II) complexes of 1,3-bis[(4-methyl-5-imidazol-1-yl)ethylideneamino]propan-2-ol and 1,3-bis[(4-methyl-5-imidazol-1-yl)ethylideneamino] propane (1999) (2)
Synthesis and crystal structure of [Y(NO3)3(OH2)3]·(Me2-16-crown-5)·H2O (1998) (2)
Synthesis, crystal structures, electrochemical and spectroscopic properties of ruthenium(II) complexes containing diamino-1,3,5-triazine derivatives (2010) (1)
β-Biguanidinium-cyclodextrin: a supramolecular mimic of mitochondrial ADP/ATP carrier protein (2014) (1)
Synthesis, Characterization, and Acid-Base Properties of Ruthenium(II) Complexes Containing N-ethyl-4-((1,10)- phenanthroline(5,6-f )imidazol-2-yl)carbazole (2010) (1)
DFT/TDDFT STUDY ON DNA-BINDING AND SPECTRAL PROPERTIES OF "LIGHT SWITCH" COMPLEX [Ru(phen)2 (taptp)]2+ IN AQUEOUS SOLUTION (2008) (1)
Recent advances in hypoxic tumor detection (2017) (1)
Super-resolution tracking of mitochondrial dynamics with a third-row transition metal complex dye (2018) (1)
A Biodegradable Iridium(III) Coordination Polymer for Enhanced Two‐Photon Photodynamic Therapy Using an Apoptosis‐Ferroptosis Hybrid Pathway (2022) (1)
Stacking between pyrido(3,2‐f) (1,7)phenanthroline and nucleic bases (1996) (1)
Chiral RuII-PtII Complexes Inducing Telomere Dysfunction against Cisplatin-Resistant Cancer Cells. (2022) (1)
[The Interaction Between a New Water-Soluble Meso-Tetrakis(Carboxyl) Zinc(Ⅱ) Porphyrin and Human Serum Albumin]. (2016) (1)
A mitochondria-localized iridium(iii) photosensitizer for two-photon photodynamic immunotherapy against melanoma (2023) (1)
Correction to "Ultrasmall RuO2 Nanozyme Exhibiting Multienzyme-like Activity for the Prevention of Acute Kidney Injury". (2020) (1)
Insights into Metalloenzyme Microenvironments: Biomimetics Metal Complexes with a Functional Second Coordination Sphere (2014) (1)
Supramolecular Assembly of An Organoplatinum(II) Complex with Ratiometric Dual Emission for Two‐Photon Bioimaging (2020) (1)
A Mitochondrion‐Localized Two‐Photon Photosensitizer Generating Carbon Radicals Against Hypoxic Tumors (2020) (1)
Selectivity and Targeting of G‐Quadruplex Binders Activated by Adaptive Binding and Controlled by Chemical Kinetics (2021) (1)
Molecular structure of chloro meso-tetra(3,4,5-trimethoxyphenyl)porphyrinato iron(III) : a model compound of cytochrome P-450 active site (1990) (1)
Synthesis and spectroscopic RNA binding studies of 1⁄2 Ru ð phen Þ 2 MHPIP 2 þ (2003) (1)
Correction: Fabrication of red blood cell membrane-camouflaged Cu2-xSe nanoparticles for phototherapy in the second near-infrared window. (2020) (1)
Correction: Mitochondria-targeted Ir@AuNRs as bifunctional therapeutic agents for hypoxia imaging and photothermal therapy. (2020) (1)
Chiral rhodium(III)-azobenzene complexes as photoswitchable DNA molecular locks. (2022) (0)
Studies on the synthesis and RNA binding of ruthenium (II) polypyridine complexes (2003) (0)
CCDC 111495: Experimental Crystal Structure Determination (1999) (0)
(1-(Phenanthrolo[5,6-d]imidazol-2-yl)-3-(4,5-diphenylimidazol-2-yl)benzene (2003) (0)
The influences of central Ga atom and peripherally substituted F atoms on fluorescence properties of Corrole (2012) (0)
Cover Picture: Targeted Cellular Uptake and siRNA Silencing by Quantum‐Dot Nanoparticles Coated with β‐Cyclodextrin Coupled to Amino Acids (Chem. Eur. J. 18/2011) (2011) (0)
Photoinduced δ electron transfer in phenylene bridged Mo2 dimers. (2017) (0)
OPTICAL-INDUCED FRÉEDERICKSZ TRANSITION OF NEMATIC LIQUID CRYSTAL DOPED WITH PORPHYRINATOZINC(II) (2002) (0)
Enantioselective binding of lambda- and delta-[Ru(bpy)(2)(HPIP)]Cl2 (HPIP=2-(2-hydroxyphenyl)imidazo[4,5-f][1,10]phenanthroline) to the hexanucleotide [d(5'-GTCGAC-3')2]. (2003) (0)
Metal-to-Ligand Charge Transfer Spectra for Transition Metal Complexes of Chelated Aromatic Ligands: Theory and Experiment (1996) (0)
Study of transient luminescence of three kinds of Ru complexes bound to DNA (2008) (0)
Kinetics and mechanism of binding of A and A coordination compounds with double helical DNA (2022) (0)
Synthesis of a new iron(III) porphyrin acrylate-styrene copolymer and its catalysis for hydroxylation of cyclohexane (2007) (0)
The structural characterization of some palladium(II) complexes of 1,10-phenanthroline and amino acids by NMR spectroscopy (2010) (0)
Interaction of Human Serum Albumin and Water Soluble Cationic Pyridyl Corrole Gallium Complex (2015) (0)
[Coordination bonding driving supramolecular self-assembly of tetraphenylporphyrinatozinc (II) with imidazolyl tailed porphyrinatoiron (III) studied by fluorescence spectra and 1H NMR]. (2004) (0)
Mitochondria are the primary target in the induction of apoptosis by chiral ruthenium(II) polypyridyl complexes in cancer cells (2013) (0)
Overcome Tumour Drug Resistance with Mitochondrial-Targeting Cyclometalated Iridium(III) Complexes (2021) (0)
Model study for the bio-coordination sphere of active center in carbonic anhydrase and application into DNA cleasvage study (2003) (0)
Polypyridyl ruthenium complexes binding with nucleic acids (2001) (0)
DNA Binding and Photocleavage Study of Cationic Metalloporphyrins by Spectral Methods (2011) (0)
CCDC 1469087: Experimental Crystal Structure Determination (2016) (0)
DNA binding properties and cytotoxic activities of two trinuclear ruthenium(II) polypyridyl complexes (2014) (0)
BIS(2,2'-BIPYRIDINE)RUTHENIUM(II) COMPLEXES WITH IMIDAZO4,5-F1,10-PHENANTHROLINE OR 2-PHENYLIMIDAZO4,5-F1,10PHENANTHROLINE (1997) (0)
Crystal Structure Study of Co(II) Complexes with 2,2′‐(1,4‐Ethylenedioxyl) Dibenzoic Acid‐[Co · L · (H2O)3]n · nH2O· 0.2 nH2O (1997) (0)
[Spectroscopic investigation of the properties of axial coordination of tailed metalloporphyrins]. (1997) (0)
Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties (2020) (0)
Phosphorescent Metal Complexes as Theranostic Anticancer Agents (2015) (0)
Crystal Structure of Chloro(2,2′-bipyridine)[3-(1,10-phenanthroline-2-yl)-5,6-diphenyl-as-triazine]ruthenium(II) Perchlorate (2004) (0)
Determination of n-Octanol/Water Partition Coefficient of HNPC-A9908 (2005) (0)
OPTIMIZATION OF BIOPROCESS OF CATALASE PRODUCTION BY ASPERGILLUS NIGER USING RESPONSE SURFACE METHODOLOGY (2002) (0)
The novel magnetic properties of ferric ion on the addition of pyridines to a tailed porphyrin iron(III) complex as studied by EPR spectroscopy (1995) (0)
CCDC 654675: Experimental Crystal Structure Determination (2008) (0)
Direct observation of the ultrafast energy transfer in a porphyrin and ruthenium dyad (2009) (0)
A Mitochondria-Localized Iridium(III)-Chlorin E6 Conjugate for Synergistic Sonodynamic and Two-Photon Photodynamic Therapy Against Melanoma (2022) (0)
2’-(3’’,4’’-Methylenedioxyphenyl)imidazo[4’,5’-f]1,10-phenanthroline (2003) (0)
Structures of three cis-beta1 and three cis-beta2 isomers of [Co(trien)(aminoacidato)]2+ complexes. (2001) (0)
[The hydrogen bond between 5-(2-carboxyphenyl)-10, 15, 20-triphenylporphyrin and amino acid ester--study with UV-Vis titration and 1H-NMR]. (1999) (0)
[The study of induced circular dichroism of phenylalanine bridged metal bis-porphyrin]. (2000) (0)
Luminescence quenching in low doped polymer light-emitting diodes (2008) (0)
1-(Phenanthrolo[5,6-d]imidazol-2-yl)-3-(phenanthro[5,6-d]imidazol-2-yl)benzene (2003) (0)
Stability of ternary copper(II) complexes formed by heteroaromatic N base and a biological buffer (bicine) (1997) (0)
2-(2-Hydroxy-5-methyl-3-formylphenyl)-imidazo[4,5-f][1,10]-phenanthroline (2003) (0)
Chiral ruthenium(II) anthraquinone complexes as dual inhibitors of topoisomerases I and II (2011) (0)
Magneto-chiral Effect of Optically Active Metalloporphyrin (2000) (0)
Selectively enhanced cancer therapy by marriage of metabolic alteration and mitochondria-targeted photodynamic therapy using cyclometalated Ir ( III ) complexes † (2017) (0)
Synthesis, Subcellular Localization and Anticancer Mechanism Studies of Unsymmetrical Iridium(III) Complexes (2023) (0)
[Studies on tailed metalloporphyrin coordination compounds. IX. Synthesis of tailed porphyrin with covalently linked phenylalanine and its fluorescence property]. (1999) (0)
Studies of electron transfer between metal complexes and DNA by the DFT method and photochemistry (2003) (0)
[The visible spectra study of the conformation equilibrium of iron-metal-free porphyrin dimers]. (1999) (0)
A supramolecular cadmium(II) complex: (1,10‐phenanthroline)[tris(2‐aminoethyl)amine]cadmium(II) dinitrate hydrate (2000) (0)
Cancer cell membrane camouflaged and H2O2-activatable nanocomposites for synergistic chemotherapy and two-photon photodynamic therapy against melanoma (2023) (0)
Phosphorescent Metal Complexes as Multifunctional Anticancer Agents (2015) (0)
[Luminescence dynamics analysis on ruthenium polypyridyl complexes bonding to DNA]. (2009) (0)
Recent progress in metal complexes functionalized nanomaterials for photodynamic therapy (2023) (0)
2’-(3’’,4’’-Methylenedioxyphenyl)-imidazo[4’,5’-f]-2,9-dimethyl-1,10-phenanthroline (2004) (0)
Necroptosis Induced by Ruthenium(II) Complexes as Dual Catalytic Inhibitors of Topoisomerase I/II (2020) (0)
Front Cover: Phosphorescent Iridium(III) Complexes for Anticancer Applications (Eur. J. Inorg. Chem. 42/2020) (2020) (0)
Axial coordination mode of novel tailed porphyrin iron(III) complexes and iron(III) porphyrin dimers and their properties to activate dioxygen (1995) (0)
Metalloporphyrins Supported on Styrene-Hydroxyethyl Methacrylate Copoly-mer Microspheres: Preparation and Catalytic Performance for Hydroxylation of Cyclohexane: Metalloporphyrins Supported on Styrene-Hydroxyethyl Methacrylate Copoly-mer Microspheres: Preparation and Catalytic Performance for Hydrox (2011) (0)
CCDC 1469086: Experimental Crystal Structure Determination (2016) (0)
Bis(1,10-phenanthroline)[2-(2-pyridyl)-1H-benzimidazol-1-yl]ruthenium(II) perchlorate–toluene–acetonitrile (2/2/1) (2006) (0)
5-[o-(1-L-Phenylalanylamino)ethoxyl]phenyl-10,15,20-triphenylporphyrin (2000) (0)
Recent advances in DNA interactions with ruthenium(II) polypyridyl complexes (2014) (0)
Correction: Synthesis, characterization and anticancer mechanism studies of fluorinated cyclometalated ruthenium(ii) complexes. (2020) (0)
[Tris(2-aminoethyl)amine-κ4N]chloro(dimethyl sulfoxide-O)cobalt(III) diperchlorate (2000) (0)
Calcium-Nickel-Lithium Oxide: A High Selectivity Catalyst for the Oxidative Dehydrogenation of Ethane to Ethylene. (1994) (0)
ipod somersault on DNA for ratiometric fl uorescence imaging of small molecules in the nucleus † (2019) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Liang‐nian Ji?

Liang‐nian Ji is affiliated with the following schools:

Sun Yat-sen University
Tongji University